{"content":"<li class=\"n-box-item date-title\" data-end=\"1524196799\" data-start=\"1524110400\" data-txt=\"Monday, December 23, 2019\">Thursday, April 19, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3347112\" data-ts=\"1524175366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347112-qualcomm-filings-plans-for-1500-job-cuts-in-california\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm filings: Plans for 1,500 job cuts in California</a></h4><ul>   <li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) confirms via filings that it's cutting 1,500 jobs in California, Bloomberg reports -- a move signaled by its need to <a href=\"https://seekingalpha.com/news/3346690-bloomberg-qualcomm-begins-trimming-jobs-part-cost-cut-pledge\" target=\"_blank\">file a WARN notice</a> for mass layoffs.</li>    <li>The company will cut 1,231 jobs in San Diego starting in June.</li>    <li>It will also cut 269 positions in northern California.</li>    <li>In an eventful week for the company's deal for NXP Semiconductor, shares of Qualcomm <font color='red'>fell 4.8%</font> today; they're <font color='green'>up 0.3%</font> after hours. <a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color='red'>fell 5.2%</font> during the regular session and is <font color='green'>up 0.1%</font> in late trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346876-cnbc-qualcomm-very-concerned-mofcom-points-nxp-problems\" target=\"_blank\">CNBC: Qualcomm 'very concerned' as MOFCOM points to NXP problems</a> (Apr. 19 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346814-qualcomm-begins-layoffs-pushes-nxp-deadline-road\" target=\"_blank\">Qualcomm begins layoffs, pushes NXP deadline down the road</a> (Apr. 19 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346708-china-seeks-concessions-qualcomm-nxp-deal\" target=\"_blank\">China seeks more concessions from Qualcomm in NXP deal</a> (Apr. 19 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3347112\" data-linked=\"Qualcomm filings: Plans for 1,500 job cuts in California\" data-tweet=\"$QCOM $QCOM $NXPI - Qualcomm filings: Plans for 1,500 job cuts in California https://seekingalpha.com/news/3347112-qualcomm-filings-plans-for-1500-job-cuts-in-california?source=tweet\" data-url=\"https://seekingalpha.com/news/3347112-qualcomm-filings-plans-for-1500-job-cuts-in-california\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347108\" data-ts=\"1524173733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLNW\" target=\"_blank\">LLNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347108-after-hours-gainers-losers-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (04/19/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a> <font color='green'>+11.7%</font>. <a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a> <font color='green'>+8.5%</font>. <a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a>&nbsp;<font color='green'>+7.4%</font>. <a href='https://seekingalpha.com/symbol/SSW' title='Seaspan Corporation'>SSW</a>&nbsp;<font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>&nbsp;<font color='green'>+1.9%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='red'>-21.8%</font>. <a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a> <font color='red'>-10.2%</font>. <a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a>&nbsp;<font color='red'>-2.6%.&nbsp;</font><a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a>&nbsp;<font color='red'>-1.7%</font>. <a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>&nbsp;<font color='red'>-2.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3347108\" data-linked=\"After Hours Gainers / Losers (04/19/2018)\" data-tweet=\"$LLNW $LLNW $HEAR - After Hours Gainers / Losers (04/19/2018) https://seekingalpha.com/news/3347108-after-hours-gainers-losers-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3347108-after-hours-gainers-losers-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347107\" data-ts=\"1524173691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCI\" target=\"_blank\">RCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347107-rogersplus-4_7-on-q1-beat-paced-broad-revenue-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rogers +4.7% on Q1 beat paced by broad revenue growth</a></h4><ul>   <li>Rogers Communications (NYSE:<a href='https://seekingalpha.com/symbol/RCI' title='Rogers Communications Inc.'>RCI</a>) is <font color='green'>up 4.7%</font> in after-hours trading after <a href=\"https://seekingalpha.com/news/3347007-rogers-reports-q1-results\" target=\"_blank\">Q1 earnings</a> that beat easily on top and bottom lines and reflected the highest Q1 postpaid net additions in nine years.</li>    <li>The company added net 95,000 postpaid customers, up 35,000, and postpaid churn improved 2 basis points to 1.08%, the best Q1 rate in 15 years.</li>    <li>That strength in the company's biggest segment paced earnings though it also marked cable revenue gains, along with double-digit revenue gains and a swing to EBITDA growth in Media.</li>    <li>Adjusted net income rose 45% to C$477M. Overall EBITDA was up 14% to C$1.338B, beating an expected C$1.233B.</li>    <li>Revenue by segment (under new IFRS 15 accounting): Wireless, C$2.19B (up 9%); Cable, C$969M (up 1%); Media, C$532M (up 12%).</li>    <li>EBITDA by segment: Wireless, C$934M (up 13%); Cable, C$433M (up 4%); Media, C$23M (up from year-ago loss of C$30M).</li>     <li>For fiscal 2018, it's reiterating its January guidance for revenue gains of 3-5%; an increase in EBITDA of 5-7%; capital expenditures of C$2.65B-C$2.85B; and free cash flow up 3-5%.</li>     <li><a href=\"https://seekingalpha.com/pr/17135496-rogers-communications-reports-first-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3347107\" data-linked=\"Rogers +4.7% on Q1 beat paced by broad revenue growth\" data-tweet=\"$RCI - Rogers +4.7% on Q1 beat paced by broad revenue growth https://seekingalpha.com/news/3347107-rogersplus-4_7-on-q1-beat-paced-broad-revenue-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3347107-rogersplus-4_7-on-q1-beat-paced-broad-revenue-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347078\" data-ts=\"1524171016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLNW\" target=\"_blank\">LLNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347078-limelight-networksplus-8_5-after-beat-and-raise-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limelight Networks +8.5% after beat and raise in Q1</a></h4><ul>   <li>Limelight Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>) is <font color='green'>up 8.5%</font> after hours following a beat on top and bottom lines and some raised full-year guidance in its <a href=\"https://seekingalpha.com/news/3347003-limelight-networks-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>    <li>Revenues grew 16.5% Y/Y and were up 8% sequentially.</li>    <li>Gross margin on a GAAP basis rose 390 basis points to 51.2%.</li>    <li>In company developments, CEO Bob Lento pointed to Goldman Sachs removing a decade-long stock overhang by existing its large equity position in the company, and the resolution of litigation with Akamai Networks.</li>    <li>For 2018, it's raising revenue estimates to $198M-$202M (vs. consensus for $199.1M) and raising non-GAAP EPS estimates to $0.13-$0.17, above consensus for $0.12. In February it expected a GAAP loss for 2018 of $0.07 to $0.13; it now expects a GAAP gain of $0.07-$0.11.</li>    <li>EBITDA is forecast at $33M-$37M, up from a previous range of $32M-$36M and vs. consensus for $33.9M.</li>    <li><a href=\"https://seekingalpha.com/pr/17135484-limelight-networks-reports-record-financial-results-first-quarter-2018\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3347078\" data-linked=\"Limelight Networks +8.5% after beat and raise in Q1\" data-tweet=\"$LLNW - Limelight Networks +8.5% after beat and raise in Q1 https://seekingalpha.com/news/3347078-limelight-networksplus-8_5-after-beat-and-raise-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3347078-limelight-networksplus-8_5-after-beat-and-raise-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347066\" data-ts=\"1524170582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PF\" target=\"_blank\">PF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347066-pinnacle-foods-up-7_5-jana-discloses-stake-urges-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinnacle Foods up 7.5% as Jana discloses stake, urges sale</a></h4><ul><li>Jana Partners and 3 co-investors <a href=\"https://seekingalpha.com/filing/3981529\" target=\"_blank\">disclose a 9.5% stake</a> in Pinnacle Foods (NYSE:<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a>), and are urging the company to explore alternatives.</li><li>Shares&nbsp;<font color='green'>+7.5%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3347066\" data-linked=\"Pinnacle Foods up 7.5% as Jana discloses stake, urges sale\" data-tweet=\"$PF - Pinnacle Foods up 7.5% as Jana discloses stake, urges sale https://seekingalpha.com/news/3347066-pinnacle-foods-up-7_5-jana-discloses-stake-urges-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3347066-pinnacle-foods-up-7_5-jana-discloses-stake-urges-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347051\" data-ts=\"1524169988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAM\" target=\"_blank\">TEAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347051-atlassianminus-7_1-following-q3-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlassian -7.1% following Q3 earnings beat</a></h4><ul>   <li>Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian'>TEAM</a>) has <font color='red'>slipped 7.1%</font> postmarket after <a href=\"https://seekingalpha.com/news/3347009-atlassian-beats-0_02-beats-revenue\" target=\"_blank\">Q3 earnings</a> topped expectations and profit guidance for the current quarter was a bit short.</li>    <li>IFRS operating loss was $10.9M, narrowing from a prior-year loss of $23.1M. Non-IFRS, operating income was $38.4M, up from $24.5M.</li>    <li>IFRS net loss was $14.3M, slightly narrower than a prior-year loss of $17.5M. On a non-IFRS basis, net income was up to $24.6M from $18.9M.</li>    <li>The company added 6,587 net new customers to arrive at a total of 119,158.</li>    <li>Revenue breakout: Subscription, $105.6M (up 66.6%); Maintenance, $81.95M (up 22.2%); Perpetual license, $21.3M (up 9.1%); Other, $14.9M (up 49.3%).</li>     <li>Free cash flow was $86.4M (up 26%) after capex of $5.3M. Cash, equivalents and short-term investments came to $763.9M at quarter's end.</li>    <li>It's guiding to Q4 total revenue of $232M-$234M (vs. consensus for $232.4M); gross margin of about 85% and operating margin (non-IFRS) of 19%; and EPS of $0.12 (light of expectations for $0.14).</li>    <li>For the full year, it's guiding to revenue of $862M-$864M (vs. consensus for $857.4M); gross margin of 84% and operating margin of 19%; and EPS of $0.47-$0.48 (vs. consensus for $0.48). Free cash flow is seen at $265M-$272M, including capex of about $30M.</li>    <li><a href=\"https://investors.atlassian.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17135523-atlassian-announces-third-quarter-fiscal-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3347051\" data-linked=\"Atlassian -7.1% following Q3 earnings beat\" data-tweet=\"$TEAM - Atlassian -7.1% following Q3 earnings beat https://seekingalpha.com/news/3347051-atlassianminus-7_1-following-q3-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3347051-atlassianminus-7_1-following-q3-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347048\" data-ts=\"1524169856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347048-rite-aid-launches-offer-to-buy-up-to-700m-of-senior-debt-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite-Aid launches offer to buy up to $700M of senior debt; shares up 1% after hours</a></h4><ul><li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) commences a <a href=\"https://seekingalpha.com/pr/17135552-rite-aid-commences-offer-purchase-certain-outstanding-series-notes\" target=\"_blank\">tender offer</a> to purchase up to $700M of its 6.75% Senior Notes due 2021 and 6.125% Senior Notes due 2023 with a portion of the proceeds from the Walgreens Boots Alliance transaction.</li></ul><div class=\"tiny-share-widget\" data-id=\"3347048\" data-linked=\"Rite-Aid launches offer to buy up to $700M of senior debt; shares up 1% after hours\" data-tweet=\"$RAD - Rite-Aid launches offer to buy up to $700M of senior debt; shares up 1% after hours https://seekingalpha.com/news/3347048-rite-aid-launches-offer-to-buy-up-to-700m-of-senior-debt-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3347048-rite-aid-launches-offer-to-buy-up-to-700m-of-senior-debt-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347038\" data-ts=\"1524169688\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347038-e-trademinus-2_6-after-big-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*Trade -2.6% after big quarter</a></h4><ul><li>Q1 net income of $235M or $0.88 per share vs. $132M and $0.48 a year ago. Adjusted operating margin of 44% vs. 38%.</li><li>DARTs hit a record 309K, up 49% Y/Y.</li><li>Buybacks of 2.7M shares at average price of $52.12 each.</li><li>Higher interest rates helped, with net interest income rising to $445M from $319M a year ago. NIM of 297 basis points vs. 263.</li><li>Commissions of $137M vs. $127M; fees and other service charges of $105M vs. $86M.</li><li><a href=\"http://about.etrade.com\" target=\"_blank\">Conference call at 5 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3347008-e-trade-financial-beats-0_12-beats-revenue\" target=\"_blank\">E*TRADE Financial beats by $0.12, beats on revenue</a> (April 19)</li><li><a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>&nbsp;<font color='red'>-2.6%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3347038\" data-linked=\"E*Trade -2.6% after big quarter\" data-tweet=\"$ETFC - E*Trade -2.6% after big quarter https://seekingalpha.com/news/3347038-e-trademinus-2_6-after-big-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3347038-e-trademinus-2_6-after-big-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347024\" data-ts=\"1524168999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347024-skechers-drops-after-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers drops after guidance disappoints</a></h4><ul>     <li>Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) reports sales increased 16.5% in <a href=\"https://seekingalpha.com/pr/17135509-skechers-achieves-new-quarterly-sales-record-first-quarter-2018\" target=\"_blank\">Q4 </a>to $1.25B.</li>     <li>Comparable same store sales in company-owned stores increased 9.5% vs. 9.3% expected. The comp included a 7.0% rise in the U.S. and 17.6 % internationally.</li>     <li>Total international wholesale sales were up 17.9% to rep 54% of total sales. Domestic wholesale sales rose 8.5% during the quarter.</li>     <li>Gross margin rose 230 bps to 46.7% of sales as costs were levered down.</li>     <li>Looking ahead, Skechers sees Q2 sales of $1.120B to $1.145B vs. $1.16B consensus and EPS of $0.38 to $0.43 vs. $0.54 consensus.</li><li>The weak guidance is hitting shares. Skechers is&nbsp;<font color='red'>down 17.44%</font>&nbsp;in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3347015-skechers-eps-line-beats-revenue\" target=\"_blank\">Skechers EPS in-line, beats on revenue</a> (April 19)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3347024\" data-linked=\"Skechers drops after guidance disappoints\" data-tweet=\"$SKX - Skechers drops after guidance disappoints https://seekingalpha.com/news/3347024-skechers-drops-after-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3347024-skechers-drops-after-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347008\" data-ts=\"1524168422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347008-e-trade-financial-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*TRADE Financial beats by $0.12, beats on revenue</a></h4><ul><li>E*TRADE Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>): Q1 EPS of $0.88 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $708M (+28.0% Y/Y) <font color='green'>beats by $33.35M</font>.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/17135534-e-trade-financial-corporation-announces-first-quarter-2018-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3347008\" data-linked=\"E*TRADE Financial beats by $0.12, beats on revenue\" data-tweet=\"$ETFC - E*TRADE Financial beats by $0.12, beats on revenue https://seekingalpha.com/news/3347008-e-trade-financial-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3347008-e-trade-financial-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3347003\" data-ts=\"1524168181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLNW\" target=\"_blank\">LLNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3347003-limelight-networks-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limelight Networks beats by $0.04, beats on revenue</a></h4><ul><li>Limelight Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>): Q1 EPS of $0.06 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $52.11M (+16.5% Y/Y) <font color='green'>beats by $4.14M</font>.</li><li>Shares <font color='green'>+9.76%</font>.</li><li><a href='https://seekingalpha.com/pr/17135484-limelight-networks-reports-record-financial-results-first-quarter-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3347003\" data-linked=\"Limelight Networks beats by $0.04, beats on revenue\" data-tweet=\"$LLNW - Limelight Networks beats by $0.04, beats on revenue https://seekingalpha.com/news/3347003-limelight-networks-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3347003-limelight-networks-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346994\" data-ts=\"1524166543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLNG\" target=\"_blank\">GLNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346994-golar-lng-reaches-deal-to-provide-flng-vessel-for-bps-tortue-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Golar LNG reaches deal to provide FLNG vessel for BP&#39;s Tortue project</a></h4><ul>     <li>Golar LNG&nbsp;(<a href='https://seekingalpha.com/symbol/GLNG' title='Golar LNG Limited'>GLNG</a> <font color='green'>+5.6%</font>) shoots higher after announcing a preliminary agreement and Heads of Terms with <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> to <a href=\"https://seekingalpha.com/pr/17135376-golar-lng-enters-preliminary-agreement-exchanges-heads-terms-flng-vessel-phase-1a-greater\" target=\"_blank\">provide a floating LNG vessel</a> to support the development of Phase 1A of the Greater Tortue/Ahmeyin project offshore Mauritania and Senegal.</li>     <li>GLNG will proceed with front end engineering design work and be ready for a vessel conversion beginning July 1, contingent on a final investment decision for the project, expected  end 2018.</li><li>Earlier, GLNG said it <a href=\"https://seekingalpha.com/pr/17134498-golar-power-reaches-financial-closing-1_5gw-sergipe-power-project\" target=\"_blank\">secured financing</a> to proceed with the $1.74B 1.5 GW Porto de Sergipe I gas-to-power project offshore Brazil.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346994\" data-linked=\"Golar LNG reaches deal to provide FLNG vessel for BP&#39;s Tortue project\" data-tweet=\"$GLNG $GLNG $BP - Golar LNG reaches deal to provide FLNG vessel for BP&#39;s Tortue project https://seekingalpha.com/news/3346994-golar-lng-reaches-deal-to-provide-flng-vessel-for-bps-tortue-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3346994-golar-lng-reaches-deal-to-provide-flng-vessel-for-bps-tortue-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346986\" data-ts=\"1524164590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECOM\" target=\"_blank\">ECOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346986-technology-top-5-gainers-losers-of-3-00-pm-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 PM (04/19/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ZDGE' title='Zedge, Inc.'>ZDGE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SOFO' title='Sonic Foundry, Inc.'>OTC:SOFO</a> <font color='green'>+7%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MKSI' title='MKS Instruments, Inc.'>MKSI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NINE' title='Nine Energy Service, Inc.'>NINE</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3346986\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 PM (04/19/2018)\" data-tweet=\"$ECOM $ECOM $ZDGE - Technology - Top 5 Gainers / Losers as of 3:00 PM (04/19/2018) https://seekingalpha.com/news/3346986-technology-top-5-gainers-losers-of-3-00-pm-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346986-technology-top-5-gainers-losers-of-3-00-pm-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346984\" data-ts=\"1524163739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346984-rough-session-for-peso-on-election-poll\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for peso on election poll</a></h4><ul><li>The Nafta re-negotiation continues to loom, <a href=\"http://markets.businessinsider.com/news/stocks/mexican-peso-is-getting-slammed-amid-political-uncertainty-2018-4-1021597373\" target=\"_blank\">but a new poll shows</a> a big 22-point lead for leftist presidential candidate&nbsp;Andres Manuel Lopez Obrador. The election takes place in July.</li><li>The peso is&nbsp;<font color='red'>lower by nearly 1.5%</font>&nbsp;vs. the greenback, it's worst daily performance in nearly a year.</li><li>The iShares MSCI Mexico Capped ETF (<a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a> <font color='red'>-2.7%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>, <a href='https://seekingalpha.com/symbol/MXF' title='Mexico Fund'>MXF</a>, <a href='https://seekingalpha.com/symbol/MXE' title='Mexico Equity&Income Fund'>MXE</a>, <a href='https://seekingalpha.com/symbol/DBMX' title='Deutsche X-trackers MSCI Mexico Hedged Equity ETF'>DBMX</a>, <a href='https://seekingalpha.com/symbol/HEWW' title='iShares Currency Hedged MSCI Mexico ETF'>HEWW</a>, <a href='https://seekingalpha.com/symbol/MEXX' title='Direxion Daily MSCI Mexico Bull 3X ETF'>MEXX</a>, <a href='https://seekingalpha.com/symbol/FLMX' title='Franklin FTSE Mexico ETF'>FLMX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346984\" data-linked=\"Rough session for peso on election poll\" data-tweet=\"$EWW $MXF $MXE - Rough session for peso on election poll https://seekingalpha.com/news/3346984-rough-session-for-peso-on-election-poll?source=tweet\" data-url=\"https://seekingalpha.com/news/3346984-rough-session-for-peso-on-election-poll\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346982\" data-ts=\"1524162197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBUU\" target=\"_blank\">MBUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346982-weak-sales-data-sends-boating-stocks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak sales data sends boating stocks lower</a></h4><ul>     <li>Boating stocks are weaker on what Bloomberg is attributing to weak sales volume data for March across several key categories. February tallies were also revised downward to add more selling pressure.</li>     <li>Decliners include Malibu Boats (<a href='https://seekingalpha.com/symbol/MBUU' title='Malibu Boats, Inc.'>MBUU</a> <font color='red'>-1.7%</font>) MCBC Holdings (<a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a> <font color='red'>-2%</font>), Brunswick (<a href='https://seekingalpha.com/symbol/BC' title='Brunswick Corporation'>BC</a> <font color='red'>-3.4%</font>), Johnson Outdoors (<a href='https://seekingalpha.com/symbol/JOUT' title='Johnson Outdoors Inc.'>JOUT</a> <font color='red'>-2.8%</font>) and MarineMax (<a href='https://seekingalpha.com/symbol/HZO' title='MarineMax Inc.'>HZO</a> <font color='red'>-1.1%</font>).</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3346982\" data-linked=\"Weak sales data sends boating stocks lower\" data-tweet=\"$MBUU $MBUU $MCFT - Weak sales data sends boating stocks lower https://seekingalpha.com/news/3346982-weak-sales-data-sends-boating-stocks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3346982-weak-sales-data-sends-boating-stocks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346980\" data-ts=\"1524161871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346980-investors-mull-gileads-filgotinib-in-wake-of-eli-lillys-incytes-baricitinib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors mull Gilead&#39;s filgotinib in wake of Eli Lilly&#39;s/Incyte&#39;s baricitinib</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/news/3346815-eli-lilly-incyte-premarket-ahead-bearish-outlook-ad-com-review-arthritis-med-baricitinib\" target=\"_blank\">this morning raised concern</a> over Eli Lilly's and Incyte's baricitinib for adults with active rheumatoid arthritis. The news sent both names for a loop, but they've since recovered to just moderate losses.</li><li>Gilead's (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='red'>-2%</font>)&nbsp;filgotinib is a similar drug being licensed from Galapagos (<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='green'>+1%</font>).</li><li>RBC's Brain Abrahams, <a href=\"https://www.marketwatch.com/story/gilead-shares-drop-on-fda-concerns-with-similar-eli-lilly-incyte-drug-2018-04-19\" target=\"_blank\">however, isn't seeing</a> any major read-throughs in either direction for&nbsp;filgotinib, noting reviewers&nbsp;made a point that thrombosis is likely not a class effect.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346980\" data-linked=\"Investors mull Gilead&#39;s filgotinib in wake of Eli Lilly&#39;s/Incyte&#39;s baricitinib\" data-tweet=\"$GILD $GILD $GLPG - Investors mull Gilead&#39;s filgotinib in wake of Eli Lilly&#39;s/Incyte&#39;s baricitinib https://seekingalpha.com/news/3346980-investors-mull-gileads-filgotinib-in-wake-of-eli-lillys-incytes-baricitinib?source=tweet\" data-url=\"https://seekingalpha.com/news/3346980-investors-mull-gileads-filgotinib-in-wake-of-eli-lillys-incytes-baricitinib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346976\" data-ts=\"1524160887\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABSCF\" target=\"_blank\">ABSCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346976-ab-science-strikes-out-in-europe-masitinib-for-als\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AB Science strikes out in Europe with masitinib for ALS</a></h4><ul><li>AB Science SA (<a href='https://seekingalpha.com/symbol/ABSCF' title='AB Science, Paris'>OTCPK:ABSCF</a>) <a href=\"https://seekingalpha.com/pr/17135328-ab-science-announces-chmp-adopted-negative-opinion-marketing-authorization-masitinib\" target=\"_blank\">reports </a>that the European Medicines Agency's advisory group CHMP has adopted a negative opinion against approving tyrosine kinase inhibitor masitinib for the treatment of adults with amyotrophic lateral sclerosis &#40;ALS&#41;. The Committee&nbsp;stated that the data were not robust enough to support approval.</li><li>The company says it will conduct additional analyses of the data as part of the re-examination procedure. A second opinion from CHMP should be issued in July.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346976\" data-linked=\"AB Science strikes out in Europe with masitinib for ALS\" data-tweet=\"$ABSCF - AB Science strikes out in Europe with masitinib for ALS https://seekingalpha.com/news/3346976-ab-science-strikes-out-in-europe-masitinib-for-als?source=tweet\" data-url=\"https://seekingalpha.com/news/3346976-ab-science-strikes-out-in-europe-masitinib-for-als\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346975\" data-ts=\"1524160848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXC\" target=\"_blank\">MXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346975-energy-materials-top-5-gainers-losers-of-2-00-pm-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (04/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-63%</font>. <a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346975\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (04/19/2018)\" data-tweet=\"$MXC $MXC $ROSE - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (04/19/2018) https://seekingalpha.com/news/3346975-energy-materials-top-5-gainers-losers-of-2-00-pm-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346975-energy-materials-top-5-gainers-losers-of-2-00-pm-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346972\" data-ts=\"1524160265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWPH\" target=\"_blank\">GWPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346972-fda-advisory-committee-backs-gw-pharmas-cannabidiol-for-rare-forms-for-epilepsy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA advisory committee backs GW Pharma&#39;s cannabidiol for rare forms for epilepsy</a></h4><ul><li>The FDA's Peripheral and Central Nervous System Drugs Advisory Committee has <a href=\"https://seekingalpha.com/pr/17135275-gw-pharmaceuticals-u-s-subsidiary-greenwich-biosciences-announces-unanimous-positive-result\" target=\"_blank\">voted </a>13 - 0 backing approval for GW Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a> <font color='green'>+0.9%</font>) cannabidiol oral solution for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.</li><li>The FDA's action date for its review of the marketing application is June 27.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346166-outlook-positive-gw-pharmas-cannabidiol-oral-solution-shares-10-percent\" target=\"_blank\">Outlook positive for GW Pharma's cannabidiol oral solution; shares up 10%</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346972\" data-linked=\"FDA advisory committee backs GW Pharma&#39;s cannabidiol for rare forms for epilepsy\" data-tweet=\"$GWPH - FDA advisory committee backs GW Pharma&#39;s cannabidiol for rare forms for epilepsy https://seekingalpha.com/news/3346972-fda-advisory-committee-backs-gw-pharmas-cannabidiol-for-rare-forms-for-epilepsy?source=tweet\" data-url=\"https://seekingalpha.com/news/3346972-fda-advisory-committee-backs-gw-pharmas-cannabidiol-for-rare-forms-for-epilepsy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346961\" data-ts=\"1524159117\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASMIY\" target=\"_blank\">ASMIY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346961-asm-international-falls-short-and-chipmakers-stay-in-downdraft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ASM International falls short and chipmakers stay in downdraft</a></h4><ul>   <li>Adding to general chip-industry malaise today, ASM International (<a href='https://seekingalpha.com/symbol/ASMIY' title='ASM International N.V.'>OTCQX:ASMIY</a>) has reported <a href=\"https://seekingalpha.com/news/3346930-asm-international-reports-q1-results\" target=\"_blank\">Q1 earnings</a> where profit margin fell and sales disappointed management.</li>    <li>\"Our sales were at the lower end of our guidance while order intake was at the higher end of our guidance. The gross margin in Q1 at 38% was impacted by an unfavorable product mix and costs related to our preparation for further growth,\" says CEO Chuck del Prado.</li>    <li>Shares are now <font color='red'>down 3.7%</font>.</li>    <li>Earlier, Taiwan Semiconductor (<a href=\"http://seekingalpha.com/symbol/TSM\" target=\"_blank\">TSM</a> <font color='red'>-6.2%</font>) cut its guidance with a <a href=\"https://seekingalpha.com/news/3346863-taiwan-semi-phone-based-softness-dragging-apple-chipmakers\" target=\"_blank\">strong pointer</a> to iPhone (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) weakness, and the combined news has weighed on chipmakers today. Apple's now <font color='red'>off 2.4%</font>.</li>    <li>Still lower on the day: <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-3.2%</font>; <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-3%</font>; <a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-3.6%</font>; <a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='red'>-4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346961\" data-linked=\"ASM International falls short and chipmakers stay in downdraft\" data-tweet=\"$ASMIY $ASMIY $AAPL - ASM International falls short and chipmakers stay in downdraft https://seekingalpha.com/news/3346961-asm-international-falls-short-and-chipmakers-stay-in-downdraft?source=tweet\" data-url=\"https://seekingalpha.com/news/3346961-asm-international-falls-short-and-chipmakers-stay-in-downdraft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346955\" data-ts=\"1524158519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346955-breakeven-cost-for-bitcoin-mining-is-8_6k-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Breakeven cost for bitcoin mining is $8.6K - Morgan Stanley</a></h4><ul><li>That $8.6K is for large mining pools with a very low cost for electricity ($0.03 per kW/h), according<a href=\"https://www.cnbc.com/2018/04/19/bitcoin-miners-are-losing-money-at-any-price-below-8600-morgan-stanley.html\" target=\"_blank\"> to analyst Charlie Chan and team</a>. Even with a recent rally, the price of bitcoin has been below that level for some time, and Chan expects even further decline in demand for mining hardware and chips.</li><li>Indeed, Taiwan Semiconductor (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a> <font color='red'>-6.1%</font>) is leading <a href=\"https://seekingalpha.com/news/3346863-taiwan-semi-phone-based-softness-dragging-apple-chipmakers\" target=\"_blank\">the semis down today</a> after it cut guidance, in part thanks to uncertainty over crypto mining demand. Nvidia (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-3.4%</font>)</li><li>Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) today is up marginally to $8,268.</li><li><a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>&nbsp;<font color='green'>+3.2%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3346955\" data-linked=\"Breakeven cost for bitcoin mining is $8.6K - Morgan Stanley\" data-tweet=\"$TSM $TSM $NVDA - Breakeven cost for bitcoin mining is $8.6K - Morgan Stanley https://seekingalpha.com/news/3346955-breakeven-cost-for-bitcoin-mining-is-8_6k-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3346955-breakeven-cost-for-bitcoin-mining-is-8_6k-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346954\" data-ts=\"1524158308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346954-novartis-q1-results-weigh-on-pharma-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis Q1 results weigh on pharma stocks</a></h4><ul><li>Big Biopharma and generic drug makers are in the red, pressured by Novartis' (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color='red'>-3.1%</font>) Q1 results that included 6% of price erosion in its Sandoz unit and less-than-expected sales of Cosentyx.</li><li>Shire plc (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+0.3%</font>) is now treading water after Allergan announced that it would not submit a bid leaving only Takeda, who may not have the resolve to pay what Shire demands.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-2%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-3.8%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-1.7%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='red'>-0.6%</font>)(<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='red'>-1.1%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-2.3%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-0.4%</font>)(VRX <font color='red'>-2.5%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-2.7%</font>)(<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt PLC'>MNK</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='red'>-0.9%</font>)(<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-3.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346954\" data-linked=\"Novartis Q1 results weigh on pharma stocks\" data-tweet=\"$NVS $NVS $SHPG - Novartis Q1 results weigh on pharma stocks https://seekingalpha.com/news/3346954-novartis-q1-results-weigh-on-pharma-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3346954-novartis-q1-results-weigh-on-pharma-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346948\" data-ts=\"1524157452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346948-interest-rates-and-earnings-hitting-stocks-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interest rates and earnings hitting stocks today</a></h4><ul><li>Interest rates had backed off during the modest struggle for stocks over the past weeks, but equities have resumed upward, and so have rates. The 10-year Treasury yield is higher by another 4.5 basis points today to 2.92%, helping the S&amp;P 500 to a<font color='red'> 0.8% decline</font>. The Nasdaq is&nbsp;<font color='red'>off 0.85%</font>&nbsp;and the Dow&nbsp;<font color='red'>0.55%</font>.</li><li>Earnings are also leaving their mark, and soft numbers from Taiwan Semiconductor are whacking the semiconductor industry (and Apple) (<a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a> <font color='red'>-4%</font>), and Proctor &amp; Gamble and Philip Morris are helping take a chunk out of consumer names (<a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a> <font color='red'>-3.2%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a>, <a href='https://seekingalpha.com/symbol/VDC' title='Vanguard Consumer Staples ETF'>VDC</a>, <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='PowerShares Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/RHS' title='Guggenheim S&P Equal Weight Consumer Staples ETF'>RHS</a>, <a href='https://seekingalpha.com/symbol/FSTA' title='Fidelity MSCI Consumer Staples Index ETF'>FSTA</a>, <a href='https://seekingalpha.com/symbol/FXG' title='First Trust Consumer Staples AlphaDEX ETF'>FXG</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a>, <a href='https://seekingalpha.com/symbol/CNSF' title='iShares Edge MSCI Multifactor Consumer Staples ETF'>CNSF</a>, <a href='https://seekingalpha.com/symbol/JHMS' title='John Hancock Multifactor Consumer Staples ETF'>JHMS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346948\" data-linked=\"Interest rates and earnings hitting stocks today\" data-tweet=\"$SOXX $XLP $VDC - Interest rates and earnings hitting stocks today https://seekingalpha.com/news/3346948-interest-rates-and-earnings-hitting-stocks-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3346948-interest-rates-and-earnings-hitting-stocks-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346943\" data-ts=\"1524157233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCBI\" target=\"_blank\">TCBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346943-financials-top-gainers-losers-of-1-00-pm-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (04/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TCBI' title='Texas Capital Bancshares, Inc.'>TCBI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EWBC' title='East West Bancorp, Inc.'>EWBC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CPSS' title='Consumer Portfolio Services, Inc.'>CPSS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CART' title='Carolina Trust Bank'>CART</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group, Inc.'>WPG</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346943\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (04/19/2018)\" data-tweet=\"$TCBI $TCBI $CIFS - Financials - Top Gainers / Losers as of 1:00 PM (04/19/2018) https://seekingalpha.com/news/3346943-financials-top-gainers-losers-of-1-00-pm-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346943-financials-top-gainers-losers-of-1-00-pm-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346938\" data-ts=\"1524156316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346938-shire-retraces-on-allergan-pass\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire retraces on Allergan pass</a></h4><ul><li>Shire plc (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+0.5%</font>) has given back most of its earlier gains following Allergan's <a href=\"https://www.cnbc.com/faber-report/\" target=\"_blank\">statement</a> that it will not bid for the company, leaving Takeda, at this point, as the lone suitor.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346938\" data-linked=\"Shire retraces on Allergan pass\" data-tweet=\"$SHPG - Shire retraces on Allergan pass https://seekingalpha.com/news/3346938-shire-retraces-on-allergan-pass?source=tweet\" data-url=\"https://seekingalpha.com/news/3346938-shire-retraces-on-allergan-pass\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346932\" data-ts=\"1524156293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346932-steel-dynamics-reports-strong-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Dynamics reports strong Q1 results</a></h4><ul>     <li>Steel Dynamics (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-0.8%</font>) reported Q1 sales growth of 9.75 Y/Y to $2.6B, due to improved demand and product pricing.</li>     <li>Segment sales: steel +10.4% Y/Y to $1.92B, fabrication +3.67% Y/Y to $201.5M, metals recycling +6.26% Y/Y to $288.12M and others +3.8% Y/Y to $92.47M.</li>     <li>Q1 Margins: Gross<font color='red'> declined by 214 bps</font>&nbsp;to 17.8%; operating <font color='red'>declined by 171 bps</font>&nbsp;to 12.42% and Adjusted EBITDA&nbsp;<font color='red'>declined by 241 bps</font>&nbsp;to 15.4%.</li>     <li>Average product selling price for steel operations was $822 per ton.</li>     <li>Cash flow from operations was $178M.</li>     <li>\"We remain confident that current and anticipated macroeconomic and market conditions are in place to benefit domestic steel consumption in 2018&rdquo;, said Mr. Mark D. Millet, President and CEO.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3346681-steel-dynamics-beats-0_04-beats-revenue\" target=\"_blank\">Steel Dynamics beats by $0.04, beats on revenue</a> (April 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346932\" data-linked=\"Steel Dynamics reports strong Q1 results\" data-tweet=\"$STLD - Steel Dynamics reports strong Q1 results https://seekingalpha.com/news/3346932-steel-dynamics-reports-strong-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346932-steel-dynamics-reports-strong-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346936\" data-ts=\"1524156025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECOM\" target=\"_blank\">ECOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346936-midday-gainers-losers-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (04/19/2018)</a></h4><ul>     <li><strong>Gainers:</strong>&nbsp;<a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+18%</font>. EBIO <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/PRAN' title='Prana Biotechnology Ltd'>PRAN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CCRC' title='China Customer Relations Centers Inc'>CCRC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corp'>DXR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a> <font color='green'>+9%</font>.</li><li><strong>Losers:</strong> ARGS <font color='red'>-65%</font>. <a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a> <font color='red'>-62%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services'>TUSK</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='red'>-15%</font>.</li>     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3346936\" data-linked=\"Midday Gainers / Losers (04/19/2018)\" data-tweet=\"$ECOM $ECOM $OPGN - Midday Gainers / Losers (04/19/2018) https://seekingalpha.com/news/3346936-midday-gainers-losers-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346936-midday-gainers-losers-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346934\" data-ts=\"1524155874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPGN\" target=\"_blank\">OPGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346934-opgen-up-15-on-positive-study-rapid-diagnostic-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OpGen up 15% on positive study with rapid diagnostic test</a></h4><ul><li>OpGen (<a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+14.8%</font>) is up on a healthy 24x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17134961-opgen-completes-rapid-testing-clinical-trial-colombia-expands-international-operations\" target=\"_blank\">announcement </a>of positive results from a Colombia-based clinical trial that showed how the OpGen rapid diagnostic test helped improve survival and reduced antibiotic use by quickly identifying bacteremia and fungemia in hospital ICU patients.</li><li>Buoyed by the successful outcome, the company has established a subsidiary there to commercialize its precision medicine products, first in Colombia, then the rest of Latin America. It expects to launch its <a href=\"http://www.opgen.com/pathogenid/quickfish-products/\" target=\"_blank\">QuickFISH </a>line in Colombia later this quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346934\" data-linked=\"OpGen up 15% on positive study with rapid diagnostic test\" data-tweet=\"$OPGN - OpGen up 15% on positive study with rapid diagnostic test https://seekingalpha.com/news/3346934-opgen-up-15-on-positive-study-rapid-diagnostic-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3346934-opgen-up-15-on-positive-study-rapid-diagnostic-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346914\" data-ts=\"1524154764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMI\" target=\"_blank\">VMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346914-valmont-industries-positive-on-q1-results-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valmont Industries positive on Q1 results, upside guidance</a></h4><ul><li>Valmont Industries (<a href='https://seekingalpha.com/symbol/VMI' title='Valmont Industries, Inc.'>VMI</a> <font color='green'>+0.8%</font>) reported Q1 sales growth of 9.6% Y/Y to $698.68M due to increased sales in almost all segments.</li><li>Segment sales: infrastructure +9.8% Y/Y to $225M, utility support +4.8% Y/Y to $209.9M, costing +15.5% Y/Y to $84.9M, agriculture +12.4% Y/Y to $188M.</li><li>Q1 Margins: Gross&nbsp;<font color='red'>declined by 160 bps&nbsp;</font>to 24.2%, operating<font color='red'> declined by 99 bps&nbsp;</font>to 9.15%.</li><li>Company deployed capital for share repurchase, two acquisitions and investment in existing factories.</li><li>FY18 Outlook guidance increased: GAAP EPS $7.70-7.80 and Adjusted EPS $8-8.10, reflecting the acquisitions, share repurchase effects and restructuring.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346684-valmont-beats-0_06-beats-revenue\" target=\"_blank\">Valmont beats by $0.06, beats on revenue</a> (April 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346914\" data-linked=\"Valmont Industries positive on Q1 results, upside guidance\" data-tweet=\"$VMI - Valmont Industries positive on Q1 results, upside guidance https://seekingalpha.com/news/3346914-valmont-industries-positive-on-q1-results-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3346914-valmont-industries-positive-on-q1-results-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346929\" data-ts=\"1524154342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346929-margin-anxiety-around-united-rentals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margin anxiety around United Rentals</a></h4><ul><li>United Rentals (<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a> <font color='red'>-5.6%</font>) trades lower despite posting higher Q1 revenue and net income.</li><li>Investors are latching on to the company's gross margin rate that came in below estimates (37.3% vs. 39.3% consensus). Higher delivery costs and equipment rental fees impacted United Rentals's bottom line during the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346621-united-rentals-beats-0_44-beats-revenue\" target=\"_blank\">United Rentals beats by $0.44, beats on revenue</a> (April 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346929\" data-linked=\"Margin anxiety around United Rentals\" data-tweet=\"$URI - Margin anxiety around United Rentals https://seekingalpha.com/news/3346929-margin-anxiety-around-united-rentals?source=tweet\" data-url=\"https://seekingalpha.com/news/3346929-margin-anxiety-around-united-rentals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346926\" data-ts=\"1524153641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEX\" target=\"_blank\">MTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346926-consumer-top-gainers-losers-of-12-00-pm-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (04/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MTEX' title='Mannatech, Incorporated'>MTEX</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a> <font color='red'>-16%</font>. AOI <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ESCA' title='Escalade, Incorporated'>ESCA</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346926\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (04/19/2018)\" data-tweet=\"$MTEX $MTEX $PM - Consumer - Top Gainers / Losers as of 12:00 PM (04/19/2018) https://seekingalpha.com/news/3346926-consumer-top-gainers-losers-of-12-00-pm-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346926-consumer-top-gainers-losers-of-12-00-pm-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346925\" data-ts=\"1524153286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPG\" target=\"_blank\">PPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346925-ppgminus-3-internal-report-of-accounting-violations-sparks-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PPG -3% as internal report of accounting violations sparks probe</a></h4><ul>     <li>PPG&nbsp;Industries (<a href='https://seekingalpha.com/symbol/PPG' title='PPG Industries, Inc.'>PPG</a> <font color='red'>-3%</font>) plunges after mixed <a href=\"https://seekingalpha.com/news/3346868-ppg-misses-0_02-beats-revenue\" target=\"_blank\">Q1 results</a> are overshadowed by disclosure of an <a href=\"https://www.marketwatch.com/story/ppg-probes-internal-report-of-accounting-issue-2018-04-19\" target=\"_blank\">accounting problem</a> that it is now investigating.</li>     <li>PPG says as it was finalizing its earnings report, it was notified through its internal reporting system of potential violations of accounting policies and procedures regarding the failure to accrue certain specified expenses.</li>     <li>In a preliminary review, PPG says it identified ~$1.4M of expenses that should have been accrued in Q1, and the latest earnings report reflect this accrual; the report also alleges as much as $5M in other unspecified expenses that were improperly not accrued in the quarter.</li>     <li>PPG's audit committee is investigating the matter, but the company says it is unable to predict the timing or outcome of the inquiry.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346925\" data-linked=\"PPG -3% as internal report of accounting violations sparks probe\" data-tweet=\"$PPG - PPG -3% as internal report of accounting violations sparks probe https://seekingalpha.com/news/3346925-ppgminus-3-internal-report-of-accounting-violations-sparks-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3346925-ppgminus-3-internal-report-of-accounting-violations-sparks-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346917\" data-ts=\"1524152570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UFPI\" target=\"_blank\">UFPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346917-universal-forest-down-6-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Forest down 6% post Q1 results</a></h4><ul><li>Universal Forest (<a href='https://seekingalpha.com/symbol/UFPI' title='Universal Forest Products, Inc.'>UFPI</a> <font color='red'>-5.9%</font>) <a href=\"https://seekingalpha.com/filing/3980228\" target=\"_blank\">reports Q1</a> revenue of $993.86M (+17.5% Y/Y); of which retail was $370.9M (+19% Y/Y); industrial $333M (+19% Y/Y);&nbsp;&amp; $307.7M (+16% Y/Y) for construction.</li><li>Gross margin was down&nbsp;<font color='red'>111 bps</font>&nbsp;to 13.2% &amp; operating margin was marginally up&nbsp;<font color='green'>45 bps</font>&nbsp;to 4.4%.</li><li>Net earnings $32.8M (+56% Y/Y); EBITDA, excluding the net gain on the sale of assets was $53.4 M (+14% Y/Y) &amp; cash &amp; equivalents was $25.3M (+18.3% Q/Q).</li><li>9% gross unit sales growth came 5% from organic sales growth and 4% from acquisition; New product sales was $103.9M (+20.5% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346617-universal-forest-products-beats-0_11-beats-revenue\" target=\"_blank\">Universal Forest Products beats by $0.11, beats on revenue</a> (April 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346917\" data-linked=\"Universal Forest down 6% post Q1 results\" data-tweet=\"$UFPI - Universal Forest down 6% post Q1 results https://seekingalpha.com/news/3346917-universal-forest-down-6-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346917-universal-forest-down-6-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346921\" data-ts=\"1524151867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346921-linn-energy-to-split-in-two-ceo-ellis-to-retire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy to split in two; CEO Ellis to retire</a></h4><ul>     <li>Linn Energy (LNGG <font color='green'>+2.3%</font>) is higher after unveiling a plan to <a href=\"https://www.chron.com/business/energy/article/Formerly-bankrupt-Linn-Energy-further-12847313.php\" target=\"_blank\">split into two new companies</a> later this year under new leadership.</li>     <li>Riviera Resources will oversee Linn's east Texas, Louisiana, Midwest and Mid-Continent oil and gas assets, as well as the Blue Mountain Midstream pipeline subsidiary, under the RVRA ticker.</li>     <li>Linn's primary assets in Oklahoma will stay under Linn as the company converts into Roan Resources, with ROAN ticker and plans to trade on the NYSE or Nasdaq later this year.</li>     <li>Linn CFO David Rottino, who joined the company in 2015, will become Riviera's CEO, and former EOG Resources executive Tony Maranto will take over as Roan's CEO; Mark Ellis, Linn&rsquo;s current President and CEO, will retire along with much of the company's current top management.</li>     <li>LNGG shareholders ultimately would receive one share in each of the two new companies.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346921\" data-linked=\"Linn Energy to split in two; CEO Ellis to retire\" data-tweet=\"$ROAN - Linn Energy to split in two; CEO Ellis to retire https://seekingalpha.com/news/3346921-linn-energy-to-split-in-two-ceo-ellis-to-retire?source=tweet\" data-url=\"https://seekingalpha.com/news/3346921-linn-energy-to-split-in-two-ceo-ellis-to-retire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346919\" data-ts=\"1524151654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346919-ten-year-treasury-yield-charges-towards-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ten-year Treasury yield charges towards 3%</a></h4><ul><li>Rising long-term interest rates took a breather for the past few weeks thanks to some stumbles in equity markets.</li><li>The business of buying low and selling high (in stocks) seems to have resumed though, and yields are back on the march. Down as low as 2.7% a couple of weeks ago, the 10-year Treasury yield today is up another five basis points today to 2.92%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-1.05%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+1.1%</font></li><li>The move in rates is hitting income favorites like REITs (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-1.5%</font>), (<a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a> <font color='red'>-1.5%</font>), and utilities (<a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='red'>-0.4%</font>). Also sensitive to rates, homebuilders <a href=\"https://seekingalpha.com/news/3346904-another-rough-session-homebuilders\" target=\"_blank\">are off big today</a> and&nbsp;<font color='red'>more than 14%</font>&nbsp;YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346919\" data-linked=\"Ten-year Treasury yield charges towards 3%\" data-tweet=\"$TLT $TBT $IYR - Ten-year Treasury yield charges towards 3% https://seekingalpha.com/news/3346919-ten-year-treasury-yield-charges-towards-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3346919-ten-year-treasury-yield-charges-towards-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346912\" data-ts=\"1524150726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABBV\" target=\"_blank\">ABBV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346912-abbvie-down-2-on-investor-concerns-potential-interest-in-shire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AbbVie down 2% on investor concerns with potential interest in Shire</a></h4><ul><li>Investors in AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-2.2%</font>) are signaling their enthusiasm for a possible run at Shire plc (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+4.6%</font>). It is only speculation since nothing has been announced.</li><li>Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-6.3%</font>) and Takeda (TKPYY <font color='green'>+0.1%</font>) are currently in the mix for the rare disease pharma firm.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346852-shire-rejects-undervalued-takeda-bid\" target=\"_blank\">Shire rejects \"undervalued\" Takeda bid</a> (April 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346870-allergan-mix-shire\" target=\"_blank\">Allergan in the mix for Shire</a> (April 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346912\" data-linked=\"AbbVie down 2% on investor concerns with potential interest in Shire\" data-tweet=\"$ABBV $ABBV $SHPG - AbbVie down 2% on investor concerns with potential interest in Shire https://seekingalpha.com/news/3346912-abbvie-down-2-on-investor-concerns-potential-interest-in-shire?source=tweet\" data-url=\"https://seekingalpha.com/news/3346912-abbvie-down-2-on-investor-concerns-potential-interest-in-shire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346911\" data-ts=\"1524150491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTY\" target=\"_blank\">PRTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346911-baml-sees-party-city-running-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML sees Party City running to new high</a></h4><ul> <li>Party City (<a href='https://seekingalpha.com/symbol/PRTY' title='Party City Holdco, Inc.'>PRTY</a> <font color='green'>+2.6%</font>) trades higher after Bank of America Merrill Lynch upgrades the retailer to Buy from Hold. The analyst team expects comparable sales pressures to ease off.</li> <li>BAML lifts its price objective on Party City to $20 from $17.50. The 52-week high for shares is $17.05.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3346911\" data-linked=\"BAML sees Party City running to new high\" data-tweet=\"$PRTY - BAML sees Party City running to new high https://seekingalpha.com/news/3346911-baml-sees-party-city-running-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3346911-baml-sees-party-city-running-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346905\" data-ts=\"1524150046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPGN\" target=\"_blank\">OPGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346905-healthcare-top-5-gainers-losers-of-11-00-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OPGN' title='OpGen'>OPGN</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corp'>DXR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a> <font color='green'>+11%</font>. EBIO <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> ARGS <font color='red'>-65%</font>. <a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346905\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/19/2018)\" data-tweet=\"$OPGN $OPGN $DXR - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (04/19/2018) https://seekingalpha.com/news/3346905-healthcare-top-5-gainers-losers-of-11-00-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346905-healthcare-top-5-gainers-losers-of-11-00-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346904\" data-ts=\"1524149707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOL\" target=\"_blank\">TOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346904-another-rough-session-for-homebuilders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another rough session for homebuilders</a></h4><ul><li>This just in: A combination of rising interest rates, perky prices, and a winter that won't end might not be good for the key spring season for home sales.</li><li>The iShares U.S. Home Construction ETF (BATS:<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>) is&nbsp;<font color='red'>down 3.8%</font>&nbsp;today and&nbsp;<font color='red'>14.3%&nbsp;</font>YTD.</li><li>Individual players: Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color='red'>-4.9%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='red'>-4.4%</font>), D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color='red'>-5.7%</font>), KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='red'>-6.6%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>, <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>, <a href='https://seekingalpha.com/symbol/PKB' title='Invesco Dynamic Building & Construction Portfolio ETF'>PKB</a>, <a href='https://seekingalpha.com/symbol/NAIL' title='Direxion Daily Homebuilders & Supplies Bull 3x Shares ETF'>NAIL</a>, <a href='https://seekingalpha.com/symbol/HOML' title='ETRACS Monthly Reset 2xLeveraged ISE Exclusively Homebuilders ETN'>HOML</a>, <a href='https://seekingalpha.com/symbol/CLAW' title='Direxion Daily Homebuilders & Supplies Bear 3x Shares ETF'>CLAW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346904\" data-linked=\"Another rough session for homebuilders\" data-tweet=\"$TOL $ITB $TOL - Another rough session for homebuilders https://seekingalpha.com/news/3346904-another-rough-session-for-homebuilders?source=tweet\" data-url=\"https://seekingalpha.com/news/3346904-another-rough-session-for-homebuilders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346878\" data-ts=\"1524149655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCK\" target=\"_blank\">CCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346878-crown-holdings-up-2-on-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crown Holdings up 2% on Q1 results</a></h4><ul><li>Crown Holdings (<a href='https://seekingalpha.com/symbol/CCK' title='Crown Holdings Inc.'>CCK</a> <font color='green'>+2.1%</font>) reported Q1 revenue increased by 15.8% Y/Y to $2.2B reflecting 3% increase in global beverage can volume.</li><li>Segment revenues: Americas beverages +11.1% Y/Y to $758M, European beverage +18.33% Y/Y to $371M, European food +11.4% Y/Y to $428M and Asia pacific +17.5% Y/Y to $337M.</li><li>Adjusted earnings rose by 22% Y/Y to $0.94.</li><li>Q1 overall operating margin&nbsp;<font color='red'>declined by 178 bps</font>&nbsp;to 10.06%. Segment operating margins: Americas beverage declined by 250 bps to 12.9%, European beverages&nbsp;<font color='red'>declined by 168 bps&nbsp;</font>to 14.8%, European food&nbsp;<font color='red'>declined by 37 bps</font>&nbsp;to 13.08% and Asia pacific<font color='red'> declined by 97 bps&nbsp;</font>to 13.06%.</li><li>Q2 2018 Outlook: Adjusted EPS $1.55-1.65 vs. consensus of $1.60.</li><li>FY 2018: Adjusted EPS $5.35-5.55; tax rate 25-26%&nbsp;adjusted cash flow $625M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346668-crown-holdings-beats-0_14-beats-revenue\" target=\"_blank\">Crown Holdings beats by $0.14, beats on revenue</a> (April 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346878\" data-linked=\"Crown Holdings up 2% on Q1 results\" data-tweet=\"$CCK - Crown Holdings up 2% on Q1 results https://seekingalpha.com/news/3346878-crown-holdings-up-2-on-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346878-crown-holdings-up-2-on-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346902\" data-ts=\"1524149431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOCA\" target=\"_blank\">TOCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346902-tocagen-inks-commercialization-deal-apollobio-in-china-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tocagen inks commercialization deal with ApolloBio in China; shares up 6%</a></h4><ul><li>Tocagen (<a href='https://seekingalpha.com/symbol/TOCA' title='Tocagen Inc'>TOCA</a> <font color='green'>+5.6%</font>) enters into a license <a href=\"https://seekingalpha.com/pr/17134599-tocagen-apollobio-enter-license-agreement-develop-commercialize-toca-511-and-toca-fc-greater\" target=\"_blank\">agreement </a>with ApolloBio affiliate Beijing Apollo Venus Biomedical Technology for exclusive rights to commercialize lead cancer immunotherapy Toca 511 &amp; Toca FC in greater China (includes Hong Kong, Macau and Taiwan).</li><li>Under the terms of the deal, Tocagen will receive $16M upfront, $4M in near-term milestones, up to $111M in future milestones and tiered low double-digit royalties on net sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346902\" data-linked=\"Tocagen inks commercialization deal with ApolloBio in China; shares up 6%\" data-tweet=\"$TOCA - Tocagen inks commercialization deal with ApolloBio in China; shares up 6% https://seekingalpha.com/news/3346902-tocagen-inks-commercialization-deal-apollobio-in-china-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3346902-tocagen-inks-commercialization-deal-apollobio-in-china-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346896\" data-ts=\"1524148604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCBI\" target=\"_blank\">TCBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346896-texas-capital-bancshares-jumps-7_2-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Capital Bancshares jumps 7.2% after earnings</a></h4><ul>     <li>1Q18 net income of $71.9M (+69% Y/Y) due to improvement in operating results and tax reform.</li>     <li>Net interest income of $210.3M (+28.7% Y/Y) due to increase in total LHI, improved earning asset composition and the effect of increases in interest rates on loan yields.</li>     <li>NIM of 3.71% an increase of 42 bps from 1Q17 due to significant 61 bps increase in traditional LHI yields.</li>     <li>Return on average common equity was 13.39% vs. 8.60% in 1Q17.</li>     <li>Return on assets was 1.22% vs. 0.83% in 1Q17.</li>     <li><a href=\"https://seekingalpha.com/article/4163896-texas-capital-bancshares-tcbi-ceo-keith-cargill-q1-2018-results-earnings-call-transcript\" target=\"_blank\">Conference Call</a></li>     <li>Prior:  <a href=\"https://seekingalpha.com/news/3346599-texas-capital-bancshares-beats-0_03-beats-revenue\" target=\"_blank\">Texas Capital Bancshares beats by $0.03, beats on revenue</a></li>     <li><a href='https://seekingalpha.com/symbol/TCBI' title='Texas Capital Bancshares, Inc.'>TCBI</a> <font color='green'>+7.2%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3346896\" data-linked=\"Texas Capital Bancshares jumps 7.2% after earnings\" data-tweet=\"$TCBI - Texas Capital Bancshares jumps 7.2% after earnings https://seekingalpha.com/news/3346896-texas-capital-bancshares-jumps-7_2-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3346896-texas-capital-bancshares-jumps-7_2-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346893\" data-ts=\"1524148243\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346893-eia-natural-gas-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Natural Gas Inventory</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>-36 Bcf </strong>vs. -23 Bcf consensus, -19 Bcf last week.</li><li>Futures&nbsp;<font color='red'>-1.94%</font>&nbsp;to $2.684.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>,<a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346893\" data-linked=\"EIA Natural Gas Inventory\" data-tweet=\"$UNG $DGAZ $UGAZ - EIA Natural Gas Inventory https://seekingalpha.com/news/3346893-eia-natural-gas-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3346893-eia-natural-gas-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346890\" data-ts=\"1524148060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXR\" target=\"_blank\">DXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346890-daxor-up-13-on-research-supporting-efficacy-of-blood-volume-analyzer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daxor up 13% on research supporting efficacy of blood volume analyzer</a></h4><ul><li>Daxor (<a href='https://seekingalpha.com/symbol/DXR' title='Daxor Corp'>DXR</a> <font color='green'>+13.4%</font>) is up more than double normal volume on the heels of the publication of research <a href=\"https://seekingalpha.com/pr/17134874-new-study-published-annals-thoracic-surgery-daxor-s-bvaminus-100-device-reveals-unexpected\" target=\"_blank\">supporting the benefits</a> of its BVA-100 blood volume analyzer. The paper appears in this month's issue of <em>The Annals of Thoracic Surgery.&nbsp;</em></li><li>The company says the paper highlights the BVA-100's ability to illuminate intravascular fluid derangements that standard tests miss. It quantifies whole blood and red blood cell volume with 98% accuracy, informing physicians of possible anemia due to blood loss.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346890\" data-linked=\"Daxor up 13% on research supporting efficacy of blood volume analyzer\" data-tweet=\"$DXR - Daxor up 13% on research supporting efficacy of blood volume analyzer https://seekingalpha.com/news/3346890-daxor-up-13-on-research-supporting-efficacy-of-blood-volume-analyzer?source=tweet\" data-url=\"https://seekingalpha.com/news/3346890-daxor-up-13-on-research-supporting-efficacy-of-blood-volume-analyzer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346884\" data-ts=\"1524147477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346884-p-and-g-earnings-weigh-on-household-products-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">P&amp;G earnings weigh on household products stocks</a></h4><ul> <li>Household consumer product stocks are trading weak after Procter &amp; Gamble's (<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a> <font color='red'>-4%</font>) earnings report signals some pricing pressure in the U.S. and Morgan Stanley downgrades Clorox (<a href='https://seekingalpha.com/symbol/CLX' title='The Clorox Company'>CLX</a> <font color='red'>-4.9%</font>) to Underweight on broad industry concerns.</li> <li>Kimberly-Clark (<a href='https://seekingalpha.com/symbol/KMB' title='Kimberly-Clark Corporation'>KMB</a> <font color='red'>-2.5%</font>), Church &amp; Dwight (<a href='https://seekingalpha.com/symbol/CHD' title='Church & Dwight Co Inc.'>CHD</a> <font color='red'>-4.2%</font>), Edgewell Personal Care (<a href='https://seekingalpha.com/symbol/EPC' title='Edgewell Personal Care'>EPC</a> <font color='red'>-2.7%</font>), Colgate-Palmolive (<a href='https://seekingalpha.com/symbol/CL' title='Colgate-Palmolive Co.'>CL</a> <font color='red'>-2.8%</font>), Revlon (<a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='red'>-2.1%</font>), Unilever (<a href='https://seekingalpha.com/symbol/UN' title='Unilever NV'>UN</a> <font color='red'>-2.2%</font>), Energizer (<a href='https://seekingalpha.com/symbol/ENR' title='Energizer Holdings, Inc.'>ENR</a> <font color='red'>-1.2%</font>), Orchids Paper Products (<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a> <font color='red'>-0.9%</font>) and Coty COTY are all lower.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3346775-pricing-drags-p-and-g-q1\" target=\"_blank\">Pricing drags on P&amp;G in Q1</a> (April 19)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3346884\" data-linked=\"P&amp;G earnings weigh on household products stocks\" data-tweet=\"$PG $PG $CLX - P&amp;G earnings weigh on household products stocks https://seekingalpha.com/news/3346884-p-and-g-earnings-weigh-on-household-products-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3346884-p-and-g-earnings-weigh-on-household-products-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346879\" data-ts=\"1524147012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEN\" target=\"_blank\">SIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346879-fda-oks-sientra-opus-breast-implants-shares-up-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Sientra Opus breast implants; shares up 9%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17133894-sientra-receives-fda-approval-pma-supplement\" target=\"_blank\">approves </a>Sientra's (<a href='https://seekingalpha.com/symbol/SIEN' title='Sientra'>SIEN</a> <font color='green'>+9.1%</font>) supplemental marketing application seeking approval to market its OPUS-branded breast implant products manufactured by Vesta.</li><li>The company says it has implemented an improved manufacturing process for the products. A controlled rollout will continue through this quarter while manufacturing ramps up.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346879\" data-linked=\"FDA OKs Sientra Opus breast implants; shares up 9%\" data-tweet=\"$SIEN - FDA OKs Sientra Opus breast implants; shares up 9% https://seekingalpha.com/news/3346879-fda-oks-sientra-opus-breast-implants-shares-up-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3346879-fda-oks-sientra-opus-breast-implants-shares-up-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346877\" data-ts=\"1524146702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAN\" target=\"_blank\">AAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346877-aarons-falls-after-off-wall-street-warns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aaron&#39;s falls after Off Wall Street warns</a></h4><ul> <li>Shares of Aaron's (NYSE:<a href='https://seekingalpha.com/symbol/AAN' title='Aaron&#39;s Inc.'>AAN</a>) are <font color='red'>down 4.97%</font> after retailer was mentioned in a negative fashion by research firm Off Wall Street.</li><li>Aaron's is seen facing stiffer competition in the lease-to-own space.</li> <li>The decline cuts just slightly into the +50% return Aaron's has delivered over the last 52 weeks to holders.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3346877\" data-linked=\"Aaron&#39;s falls after Off Wall Street warns\" data-tweet=\"$AAN - Aaron&#39;s falls after Off Wall Street warns https://seekingalpha.com/news/3346877-aarons-falls-after-off-wall-street-warns?source=tweet\" data-url=\"https://seekingalpha.com/news/3346877-aarons-falls-after-off-wall-street-warns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346876\" data-ts=\"1524146616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346876-cnbc-qualcomm-very-concerned-mofcom-points-to-nxp-problems\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Qualcomm &#39;very concerned&#39; as MOFCOM points to NXP problems</a></h4><ul>   <li>Qualcomm (<a href=\"http://seekingalpha.com/symbol/QCOM\" target=\"_blank\">QCOM</a> <font color='red'>-4.2%</font>) is \"<a href=\"https://twitter.com/CNBCnow/status/986962197443162120\" target=\"_blank\">very concerned</a>\" with its deal for NXP Semiconductors (<a href=\"http://seekingalpha.com/symbol/NXPI\" target=\"_blank\">NXPI</a> <font color='red'>-4.7%</font>), CNBC says, after Chinese antitrust watchdog MOFCOM says there are \"problems\" with the deal that will be \"difficult to overcome.\"</li>    <li>That pointed toward <a href=\"https://seekingalpha.com/news/3346708-china-seeks-concessions-qualcomm-nxp-deal\" target=\"_blank\">further remedies</a> needed for the deal that Qualcomm may not have been prepared for, David Faber says.</li>    <li>The two companies have <a href=\"https://seekingalpha.com/news/3346814-qualcomm-begins-layoffs-pushes-nxp-deadline-road\" target=\"_blank\">extended their merger agreement</a> 90 days (with a $2B breakup fee to NXP if the deal doesn't go down), withdrawn their application and refiled with MOFCOM.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346876\" data-linked=\"CNBC: Qualcomm &#39;very concerned&#39; as MOFCOM points to NXP problems\" data-tweet=\"$QCOM $QCOM $NXPI - CNBC: Qualcomm &#39;very concerned&#39; as MOFCOM points to NXP problems https://seekingalpha.com/news/3346876-cnbc-qualcomm-very-concerned-mofcom-points-to-nxp-problems?source=tweet\" data-url=\"https://seekingalpha.com/news/3346876-cnbc-qualcomm-very-concerned-mofcom-points-to-nxp-problems\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>114&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346871\" data-ts=\"1524146174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346871-amex-up-6-post-earnings-sell-side-weighs-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmEx up 6% post-earnings as sell-side weighs in</a></h4><ul><li>Goldman's Ryan Nash is calling American Express' (NYSE:<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a>) Q1 beat the best since Q3 of 2016. Revenue is \"gaining some steam,\" and full-year guidance could prove to be conservative. Nash, nevertheless, remains Neutral on the stock.</li><li>Donald Fandetti from Wells Fargo says solid credit performance undercuts a key leg of the bear case. He's still at Outperform with $115 price target.</li><li>William Blair bull Robert Napoli says AmEx has the earnings growth outlook of a global payments/fintech company, but with the valuation of low growth regional bank. He sees more than 30% upside.</li><li>And what does a bear have to say? RBC's Jason Arnold isn't impressed that the company sees EPS towards the high end of previous guidance, and suggests this means the strong Q1 was the peak for the year. Competition and a pending DOJ lawsuit remain worries. He's at Underperform with $86 price target (up from $81).</li><li>Source: Bloomberg's Lily Katz</li><li>Shares&nbsp;<font color='green'>+5.9%</font>&nbsp;to $100.70.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346613-amex-2_5-percent-earnings-beat\" target=\"_blank\">AmEx up 2.5% after earnings beat</a> (April 18)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346605-american-express-beats-0_15-beats-revenue\" target=\"_blank\">American Express beats by $0.15, beats on revenue</a> (April 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346871\" data-linked=\"AmEx up 6% post-earnings as sell-side weighs in\" data-tweet=\"$AXP - AmEx up 6% post-earnings as sell-side weighs in https://seekingalpha.com/news/3346871-amex-up-6-post-earnings-sell-side-weighs-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3346871-amex-up-6-post-earnings-sell-side-weighs-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346870\" data-ts=\"1524146051\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346870-allergan-in-mix-for-shire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan in the mix for Shire</a></h4><ul><li>Reuters <a href=\"https://www.cnbc.com/2018/04/19/allergan-in-talks-to-acquire-shire-competing-against-takeda-pharmaceutical.html\" target=\"_blank\">reports </a>that Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-3.4%</font>) is preparing a bid for Shire plc (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color='green'>+7.4%</font>).</li><li>Allergan explored a <a href=\"https://www.reuters.com/article/uk-shire-allergan/exclusive-allergan-approached-shire-about-takeover-but-rebuffed-sources-idUKBREA3N2JE20140425\" target=\"_blank\">possible deal</a> in 2014 (tax inversion) but it failed to gain traction.</li><li><strong>Update</strong>: Allergan says it has <a href=\"https://www.bloomberg.com/news/articles/2018-04-19/allergan-is-in-early-stages-of-considering-possible-shire-offer\" target=\"_blank\">yet to submit</a> a formal bid. According to UK takeover regulations, it has until May 17 to announce its intentions.</li><li><strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17135113-allergan-issues-statement-regarding-press-speculation-strategic-review\" target=\"_blank\">statement</a>, Allergan says it is in the process of evaluating a \"full range of strategic options\" to boost shareholder value, including acquisitions, combinations and divestitures. It is in the early stages of considering a bid for Shire but no offer has been made.</li><li><strong>Update</strong>: Allergan chief Brent Saunders says there will be <a href=\"https://www.cnbc.com/faber-report/\" target=\"_blank\">no bid</a> for Shire.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346870\" data-linked=\"Allergan in the mix for Shire\" data-tweet=\"$AGN $AGN $SHPG - Allergan in the mix for Shire https://seekingalpha.com/news/3346870-allergan-in-mix-for-shire?source=tweet\" data-url=\"https://seekingalpha.com/news/3346870-allergan-in-mix-for-shire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346867\" data-ts=\"1524145841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346867-sprintplus-1_7-macquarie-lifts-to-neutral-on-consolidation-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint +1.7% as Macquarie lifts to Neutral on consolidation prospects</a></h4><ul>   <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) is <font color='green'>up 1.7%</font> after a lift to Neutral at Macquarie, whose Amy Yong has an eye toward consolidation with T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='green'>+0.5%</font>) rather than on \"rocky fundamentals including elevated churn.\"</li>    <li>She still prefers T-Mobile on fundamentals as well as support from buybacks and M&amp;A but has raised her price target on Sprint to $6.25. As for the deal, the questions still come down to getting a regulatory OK and which parent will have control: Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color='red'>-0.3%</font>) or SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='red'>-0.6%</font>). (h/t Bloomberg)</li>    <li>Sprint is <font color='red'>down 29.4%</font> over the past 12 months, while T-Mobile isn't positive over that span either: <font color='red'>down 2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346867\" data-linked=\"Sprint +1.7% as Macquarie lifts to Neutral on consolidation prospects\" data-tweet=\"$S $S $TMUS - Sprint +1.7% as Macquarie lifts to Neutral on consolidation prospects https://seekingalpha.com/news/3346867-sprintplus-1_7-macquarie-lifts-to-neutral-on-consolidation-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3346867-sprintplus-1_7-macquarie-lifts-to-neutral-on-consolidation-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346863\" data-ts=\"1524145256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346863-taiwan-semi-phone-based-softness-dragging-apple-chipmakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taiwan Semi phone-based softness dragging Apple, other chipmakers</a></h4><ul>   <li>A <a href=\"https://seekingalpha.com/news/3346811-taiwan-semi-trims-revenue-outlook-softer-smartphone-demand\" target=\"_blank\">miss and dim guidance</a> from Taiwan Semiconductor (<a href=\"http://seekingalpha.com/symbol/TSM\" target=\"_blank\">TSM</a> <font color='red'>-4.9%</font>) -- which pointed to a \"very high-end smartphone\" as part of demand softness -- is dinging Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) while other chipmakers move down.</li>    <li>Analysts say the smartphone in question is the iPhone, and Apple is <font color='red'>down 1.7%</font> shortly after today's open.</li>    <li>Chipmakers depressed out of the open include Nvidia (<a href=\"http://seekingalpha.com/symbol/NVDA\" target=\"_blank\">NVDA</a> <font color='red'>-1.7%</font>), AMD (<a href=\"http://seekingalpha.com/symbol/AMD\" target=\"_blank\">AMD</a> <font color='red'>-0.8%</font>), Intel (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color='red'>-1.9%</font>) and STMicroelectronics (<a href=\"http://seekingalpha.com/symbol/STM\" target=\"_blank\">STM</a> <font color='red'>-1.9%</font>).</li>    <li>Apple made up about 21% of Taiwan Semi's revenue in Q4, Bloomberg estimates.</li>    <li>Apple reports Q2 earnings May 1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346863\" data-linked=\"Taiwan Semi phone-based softness dragging Apple, other chipmakers\" data-tweet=\"$AAPL $AAPL $TSM - Taiwan Semi phone-based softness dragging Apple, other chipmakers https://seekingalpha.com/news/3346863-taiwan-semi-phone-based-softness-dragging-apple-chipmakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3346863-taiwan-semi-phone-based-softness-dragging-apple-chipmakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>218&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346862\" data-ts=\"1524145022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPSYY\" target=\"_blank\">MPSYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346862-morphosys-prices-ipo-25_04-per-ads-trading-commences-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MorphoSys prices IPO at $25.04 per ADS, trading commences today</a></h4><ul><li>MorphoSys AG (<a href='https://seekingalpha.com/symbol/MPSYY' title='MorphoSys AG ADR'>OTCPK:MPSYY</a>) <a href=\"https://www.morphosys.com/media-investors/media-center/morphosys-announces-pricing-of-initial-public-offering-of-american\" target=\"_blank\">prices </a>its IPO of 8.3M American Depositary Shares (ADSs) at $25.04. Each ADS represents 1/4 of an ordinary share. Trading starts today under the symbol (NASDAQ:<a href='https://seekingalpha.com/symbol/MOR' title='MorphoSys AG'>MOR</a>).</li><li>The late-stage biopharmaceutical firm has a broad pipeline of over 100 candidates, 28 in the clinic. Lead drug is MOR208 for diffuse large B-cell lymphoma.</li><li><a href=\"https://www.sec.gov/Archives/edgar/data/1340243/000119312518091996/d519754df1.htm\" target=\"_blank\">2017 Financials</a> (&euro;M): Revenues: 66.8 (+34.4%); Operating Expenses: 133.8 (+21.9%); Net Loss: (69.8) (-15.6%); Cash Consumption: (38.4) (+17.6%).</li><li><strong>Update</strong>: Shares opened at $26.16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346862\" data-linked=\"MorphoSys prices IPO at $25.04 per ADS, trading commences today\" data-tweet=\"$MPSYY $MPSYY $MOR - MorphoSys prices IPO at $25.04 per ADS, trading commences today https://seekingalpha.com/news/3346862-morphosys-prices-ipo-25_04-per-ads-trading-commences-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3346862-morphosys-prices-ipo-25_04-per-ads-trading-commences-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346856\" data-ts=\"1524144276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGSQ\" target=\"_blank\">ARGSQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346856-premarket-losers-of-9-05-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (04/19/2018)</a></h4><ul>     <li>ARGS&nbsp;<font color='red'>-67%&nbsp;</font>as <a href=\"https://seekingalpha.com/news/3346843-argos-therapeutics-bails-late-stage-study-rocapuldencel-t-kidney-cancer-shares-64-percent\" target=\"_blank\">bails</a> on late-stage study of Rocapuldencel-T in kidney cancer.</li>     <li><a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a>&nbsp;<font color='red'>-54%</font>&nbsp;as&nbsp;business <a href=\"https://seekingalpha.com/news/3346830-aceto-slumps-51-percent-premarket-business-deteriorates\" target=\"_blank\">deteriorates</a>.</li>     <li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>&nbsp;<font color='red'>-34%</font>&nbsp;on share <a href=\"https://seekingalpha.com/news/3346659-helios-matheson-analytics-announces-share-offering\" target=\"_blank\">offering</a>.</li>     <li><a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a>&nbsp;<font color='red'>-20%</font>&nbsp;on strategic <a href=\"https://seekingalpha.com/news/3346755-pier-1-imports-announces-strategic-reset\" target=\"_blank\">reset</a>.</li>     <li><a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>&nbsp;<font color='red'>-15%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3346619-sleep-number-misses-0_04-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>&nbsp;<font color='red'>-14%</font>&nbsp;on public stock <a href=\"https://seekingalpha.com/news/3346677-torchlight-energy-launch-public-stock-offering-amount-stated\" target=\"_blank\">offering</a></li>     <li><a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a>&nbsp;<font color='red'>-12%</font>&nbsp;on $125M convertible debt <a href=\"https://seekingalpha.com/news/3346604-paratek-pharma-launches-125m-convertible-debt-offering\" target=\"_blank\">offering</a>.</li>     <li><a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>&nbsp;<font color='red'>-10%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/AGLE' title='Aeglea BioTherapeutics'>AGLE</a>&nbsp;<font color='red'>-9%</font>&nbsp;on pricing stock <a href=\"https://seekingalpha.com/news/3346767-aeglea-prices-stock-offering-8\" target=\"_blank\">offering</a> at $8.</li>     <li><a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc'>PTN</a>&nbsp;<font color='red'>-6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/SFL' title='Ship Finance International Limited'>SFL</a>&nbsp;<font color='red'>-6%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/pr/17134647-sfl-ship-finance-international-limited-announces-pricing-offering-convertible-senior-notes\" target=\"_blank\">pricing</a> of notes.</li>     <li><a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a>&nbsp;<font color='red'>-5%</font>&nbsp;on Q1&nbsp;<a href=\"https://seekingalpha.com/news/3346751-philip-morris-beats-0_10-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CART' title='Carolina Trust Bank'>CART</a>&nbsp;<font color='red'>-5%</font>&nbsp;on&nbsp;pricing stock&nbsp;<a href=\"https://seekingalpha.com/pr/17134488-carolina-trust-bancshares-inc-announces-pricing-common-stock-offering\" target=\"_blank\">offering</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346856\" data-linked=\"Premarket Losers as of 9:05 am (04/19/2018)\" data-tweet=\"$ARGSQ $ARGSQ $ACET - Premarket Losers as of 9:05 am (04/19/2018) https://seekingalpha.com/news/3346856-premarket-losers-of-9-05-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346856-premarket-losers-of-9-05-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346855\" data-ts=\"1524144275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMNY\" target=\"_blank\">HMNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346855-sinking-feeling-helios-and-matheson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinking feeling at Helios and Matheson</a></h4><ul> <li>Helios and Matheson Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) is <font color='red'>down 33.68%</font> in premarket trading after yesterday's share offering announcement sent pencils flying.</li> <li>The MoviePass owner sold 10.5M Series A-2 units and 500K Series B-2 units $2.75 per share. Each A-2 unit gives a holder a share and a warrant, while a B-2 unit is one pre-funded Series B-2 warrant to purchase one common share. Peeling away the offering details, Helios is bringing in about $30.25M to fund MoviePass and potentially more deals. The equity sales agreement with Canaccord Genuity allows Helios sell up to $150M in shares over time.</li> <li>Today's share price decline is a reaction to the potential dilutive impact of the offering in the future. Expect some bulls to remind on the success of Netflix, Amazon Prime and other high-subscriber growth success stories.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346659-helios-matheson-analytics-announces-share-offering\" target=\"_blank\">Helios and Matheson&nbsp;Analytics announces share offering</a> (April 18)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3346855\" data-linked=\"Sinking feeling at Helios and Matheson\" data-tweet=\"$HMNY - Sinking feeling at Helios and Matheson https://seekingalpha.com/news/3346855-sinking-feeling-helios-and-matheson?source=tweet\" data-url=\"https://seekingalpha.com/news/3346855-sinking-feeling-helios-and-matheson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346853\" data-ts=\"1524144225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWW\" target=\"_blank\">GWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346853-w-w-graingerplus-6_75-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">W.W. Grainger +6.75% on earnings beat</a></h4><ul><li>W.W. Grainger (NYSE:<a href='https://seekingalpha.com/symbol/GWW' title='W.W. Grainger, Inc.'>GWW</a>) reports&nbsp;volume rose 8% in <a href=\"https://seekingalpha.com/pr/17134570-grainger-reports-results-2018-first-quarter\" target=\"_blank\">Q1</a>.</li><li>U.S. business sales up 8% to $2.11B, driven by a 9 percentage point from volume growth.</li><li>Canada business sales fell 2% to $181.76M.</li><li>Other businesses sales grew 18% to $588.09M.</li><li>Gross margin rate down 60 bps to 39.5%</li><li>Adjusted operating margin rate advanced 110 bps to 12.4%.</li><li><b>FY2018 Guidance</b>:&nbsp;Sales: +5% to +8%; Diluted EPS: $14.30 to $15.30; Tax rate: 23% to 26%.</li><li>GWW&nbsp;<font color='green'>+6.75%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346853\" data-linked=\"W.W. Grainger +6.75% on earnings beat\" data-tweet=\"$GWW - W.W. Grainger +6.75% on earnings beat https://seekingalpha.com/news/3346853-w-w-graingerplus-6_75-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3346853-w-w-graingerplus-6_75-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346852\" data-ts=\"1524143806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346852-shire-rejects-undervalued-takeda-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire rejects &quot;undervalued&quot; Takeda bid</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/17134788-shire-plc-statement-re-proposal-takeda-pharmaceutical-company-limited\" target=\"_blank\">statement</a>, Shire plc (NASDAQ:<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>) says the board has rejected Takeda Pharmaceutical's (TKPYY) third (and latest) bid, valued at&nbsp;&pound;44B in cash and stock because it \"continues to significantly under-value\" the company, its growth prospects and pipeline.</li><li>The offer, &pound;17.75 in cash and &pound;28.75 in Takeda shares, was Takeda's third attempt at a deal. The first two bids valued Shire at &pound;41B and &pound;43B, respectively.</li><li>Shire is up&nbsp;<font color='green'>2%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346852\" data-linked=\"Shire rejects &quot;undervalued&quot; Takeda bid\" data-tweet=\"$SHPG $SHPG $TAK - Shire rejects &quot;undervalued&quot; Takeda bid https://seekingalpha.com/news/3346852-shire-rejects-undervalued-takeda-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3346852-shire-rejects-undervalued-takeda-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346847\" data-ts=\"1524143373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPTH\" target=\"_blank\">BPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346847-premarket-gainers-of-9-05-04-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (04/19/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a> <font color='green'>+20%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3346695-bio-path-plus-38_6-percent-presentatiom-prexigebersen-data\" target=\"_blank\">presentation</a>&nbsp;of prexigebersen data.</li><li><a href='https://seekingalpha.com/symbol/SIEN' title='Sientra'>SIEN</a> <font color='green'>+12%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/pr/17133894-sientra-receives-fda-approval-pma-supplement\" target=\"_blank\">approves</a> PMA supplement allowing commercialization of its OPUS-branded breast implant products.</li><li><a href='https://seekingalpha.com/symbol/GWW' title='W.W. Grainger, Inc.'>GWW</a> <font color='green'>+7%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3346804-w-w-grainger-beats-0_76-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='green'>+6%</font>&nbsp;on Q1&nbsp;<a href=\"https://seekingalpha.com/news/3346753-neurometrix-reports-q1-results\" target=\"_blank\">result</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346847\" data-linked=\"Premarket Gainers as of 9:05 am (04/19/2018)\" data-tweet=\"$BPTH $BPTH $SIEN - Premarket Gainers as of 9:05 am (04/19/2018) https://seekingalpha.com/news/3346847-premarket-gainers-of-9-05-04-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3346847-premarket-gainers-of-9-05-04-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346843\" data-ts=\"1524143061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGSQ\" target=\"_blank\">ARGSQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346843-argos-therapeutics-bails-on-late-stage-study-of-rocapuldencel-t-in-kidney-cancer-shares-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argos Therapeutics bails on late-stage study of Rocapuldencel-T in kidney cancer; shares down 64%</a></h4><ul><li>Nano cap Argos Therapeutics (ARGS) craters&nbsp;<font color='red'>64%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17134589-argos-therapeutics-reports-results-interim-analysis-adapt-trial-announces-review-strategic\" target=\"_blank\">announcement </a>that it will terminate its Phase 3 ADAPT trial assessing lead candidate Rocapuldencel-T, combined with sunitinib/standard-of-care, in newly diagnosed patients with metastatic renal cell carcinoma. The company made its decision after interim results indicated poor prospects of success.</li><li>Median overall survival, one of the four co-primary endpoints, in the intent-to-treat population was 28.2 months in the treatment arm compared to 31.2 months for control. Two other survival-related endpoints were also unfavorable.</li><li>The company says it will explore strategic alternatives and does not expect to regain compliance with Nasdaq's $1 minimum bid price requirement by the April 24 deadline. As a result, trading in its common stock on the Nasdaq Capital Market will be suspended on April 23 at the open. An application to transfer trading to the OTCQB Venture Market has been submitted.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346843\" data-linked=\"Argos Therapeutics bails on late-stage study of Rocapuldencel-T in kidney cancer; shares down 64%\" data-tweet=\"$ARGSQ - Argos Therapeutics bails on late-stage study of Rocapuldencel-T in kidney cancer; shares down 64% https://seekingalpha.com/news/3346843-argos-therapeutics-bails-on-late-stage-study-of-rocapuldencel-t-in-kidney-cancer-shares-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3346843-argos-therapeutics-bails-on-late-stage-study-of-rocapuldencel-t-in-kidney-cancer-shares-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346830\" data-ts=\"1524142205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACET\" target=\"_blank\">ACET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346830-aceto-slumps-51-premarket-business-deteriorates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aceto slumps 51% premarket as business deteriorates</a></h4><ul><li>Citing persistent headwinds in the generics market, Aceto (NASDAQ:<a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a>) is negotiating with lenders to waive leverage and debt service covenants in order to avoid a default. Management says it expects to record an asset impairment charge of $230M - 260M on currently marketed and pipeline products due to \"intense competitive and pricing pressures.\"</li><li>Also, it has <a href=\"https://seekingalpha.com/pr/17134077-aceto-board-takes-proactive-steps-address-business-financial-challenges\" target=\"_blank\">announced </a>that its financial guidance issued on February 1 can no longer be relied upon.</li><li>CFO Edward Borkowski has resigned. Rebecca Roof will take over on an interim basis.</li><li>The company has hired financial advisor PJT Partners and legal counsel to assist in a strategic review of its business.</li><li>Shares are down&nbsp;<font color='red'>51%</font>&nbsp;premarket on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346830\" data-linked=\"Aceto slumps 51% premarket as business deteriorates\" data-tweet=\"$ACET - Aceto slumps 51% premarket as business deteriorates https://seekingalpha.com/news/3346830-aceto-slumps-51-premarket-business-deteriorates?source=tweet\" data-url=\"https://seekingalpha.com/news/3346830-aceto-slumps-51-premarket-business-deteriorates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>84&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346829\" data-ts=\"1524142126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BK\" target=\"_blank\">BK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346829-strong-markets-higher-rates-propel-bny-mellon-shares-up-3_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong markets, higher rates propel BNY Mellon; shares up 3.8%</a></h4><ul><li>Q1 net income of $1.135B or $1.10 per share vs. $880M and $0.83 a year ago. Even excluding the lower corporate tax rate and share buybacks, EPS was still up 23% Y/Y, notes CEO Charles Scharf.</li><li>Fee revenue of $3.3B up 10% Y/Y. Net interest revenue of $919M up 16%. Noninterest expenses of $2.7B up 4%.</li><li>Assets under custody and/or administration up 9% Y/Y to $33.5T. AUM up 8% to $1.9T.</li><li>11M shares bought back during Q4 for $644M. $246M paid out in dividends.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346729-bank-new-york-mellon-beats-0_14-beats-revenue\" target=\"_blank\">Bank of New York Mellon beats by $0.14, beats on revenue</a> (April 19)</li><li><a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a>&nbsp;<font color='green'>+3.8%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3346829\" data-linked=\"Strong markets, higher rates propel BNY Mellon; shares up 3.8%\" data-tweet=\"$BK - Strong markets, higher rates propel BNY Mellon; shares up 3.8% https://seekingalpha.com/news/3346829-strong-markets-higher-rates-propel-bny-mellon-shares-up-3_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3346829-strong-markets-higher-rates-propel-bny-mellon-shares-up-3_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346826\" data-ts=\"1524141938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPC\" target=\"_blank\">GPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346826-genuine-parts-reaffirms-fy2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genuine Parts reaffirms FY2018 guidance</a></h4><ul><li>Genuine Parts (NYSE:<a href='https://seekingalpha.com/symbol/GPC' title='Genuine Parts Company'>GPC</a>) reports organic growth of 2% in <a href=\"https://seekingalpha.com/pr/17134736-genuine-parts-company-reports-sales-earnings-first-quarter-ended-march-31-2018\" target=\"_blank\">Q1</a>.</li><li>Automotive group net sales rose 29.6% to $2.56B.</li><li>Industrial net sales expanded 8.3% to $1.55B.</li><li>Business Products net sales down 4.8% to $474.09M.</li><li>Gross margin rate improved 170 bps to 31.3%.</li><li>Operating margin rate slipped 40 bps to 6.9%.</li><li><b>FY2018 Guidance</b>:&nbsp;Sales: +12% to +13%; Tax rate: ~26%; Diluted EPS: $5.60 to $5.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346826\" data-linked=\"Genuine Parts reaffirms FY2018 guidance\" data-tweet=\"$GPC - Genuine Parts reaffirms FY2018 guidance https://seekingalpha.com/news/3346826-genuine-parts-reaffirms-fy2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3346826-genuine-parts-reaffirms-fy2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346825\" data-ts=\"1524141503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346825-alcoa-hit-100-metal-prices-hold-bmo-says-analysts-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa could hit $100 if metal prices hold, BMO says as analysts praise</a></h4><ul>     <li>Alcoa (NYSE:<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a>) <font color='green'>+4%</font> premarket after beating <a href=\"https://seekingalpha.com/news/3346614-alcoa-beats-0_07-beats-revenue\" target=\"_blank\">Q1 earnings</a> estimates and <a href=\"https://seekingalpha.com/news/3346658-alcoa-plus-4-percent-beating-q1-earnings-raising-2018-ebitda-guidance\" target=\"_blank\">raising 2018 EBITDA guidance</a>, sparked by the recent rally in aluminum and alumina prices.</li>     <li>BMO Capital's David Gagliano thinks the shares have the potential to hit $100 if current prices stick, given the near-term alumina squeeze; the firm rates AA at Outperform and raises its price target to $80 from $63.</li>     <li>Alcoa seems cheap when using current metal prices, Deutsche Bank says, but the sustainability of the recent rally is now the largest question mark; AA is long all three commodities of the aluminum value chain, and seems primed to return excess cash to shareholders by H2.</li>     <li>Morgan Stanley notes that at spot aluminum and alumina prices, Alcoa's free cash flow yield will be  closer to 20%, and every week prices stay at current levels, AA may generate ~$40M in free cash flow.</li>     <li>Cowen raises its AA price target to $67 from $51 as the market deciphers the  fallout from the Rusal sanctions and the alumina market remains tight,  with no clear path for Alunorte&rsquo;s return in the near-term.</li><li>Also, <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='green'>+2.6%</font> premarket.</li>     <li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346825\" data-linked=\"Alcoa could hit $100 if metal prices hold, BMO says as analysts praise\" data-tweet=\"$AA $AA $CENX - Alcoa could hit $100 if metal prices hold, BMO says as analysts praise https://seekingalpha.com/news/3346825-alcoa-hit-100-metal-prices-hold-bmo-says-analysts-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/3346825-alcoa-hit-100-metal-prices-hold-bmo-says-analysts-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346824\" data-ts=\"1524141323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCR\" target=\"_blank\">NVCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346824-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Novocure (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCR' title='NovoCure'>NVCR</a>) upgraded to Buy with a $29 (22% upside) price target at Deutsche Bank. Shares up&nbsp;<font color='green'>6%</font>&nbsp;premarket.</li><li>Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) resumed with Market Perform rating at Oppenheimer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346824\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$NVCR $NVCR $SGEN - Premarket analyst action - healthcare https://seekingalpha.com/news/3346824-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3346824-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346815\" data-ts=\"1524140924\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346815-eli-lilly-and-incyte-down-premarket-ahead-on-bearish-outlook-on-ad-com-review-for-arthritis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eli Lilly and Incyte down premarket ahead on bearish outlook on Ad Com review for arthritis med baricitinib</a></h4><ul><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) and collaboration partner Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) are down&nbsp;<font color='red'>2%</font>&nbsp;and&nbsp;<font color='red'>6%</font>, respectively, premarket in response to the release of briefing documents for next Tuesday's FDA <a href=\"https://www.fda.gov/AdvisoryCommittees/Calendar/ucm601793.htm\" target=\"_blank\">advisory committee review</a> of Lilly's marketing application seeking approval for baricitinib for adults with active rheumatoid arthritis who have not responded adequately to methotrexate.</li><li>Investors are spooked that the outcome may be another CRL (original received in April 2017). The conclusion section of the FDA's document (p. 186) begins: \"Overall, the additional data provided in the resubmission did not substantially alter the efficacy and safety data in the original submission. Thus, questions remain regarding the benefit/risk assessment of baricitinib for RA patients.\"</li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM605061.pdf\" target=\"_blank\">FDA briefing doc</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvisoryCommittee/UCM605062.pdf\" target=\"_blank\">Lilly briefing doc&nbsp;</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3346815\" data-linked=\"Eli Lilly and Incyte down premarket ahead on bearish outlook on Ad Com review for arthritis med baricitinib\" data-tweet=\"$LLY $LLY $INCY - Eli Lilly and Incyte down premarket ahead on bearish outlook on Ad Com review for arthritis med baricitinib https://seekingalpha.com/news/3346815-eli-lilly-and-incyte-down-premarket-ahead-on-bearish-outlook-on-ad-com-review-for-arthritis?source=tweet\" data-url=\"https://seekingalpha.com/news/3346815-eli-lilly-and-incyte-down-premarket-ahead-on-bearish-outlook-on-ad-com-review-for-arthritis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346811\" data-ts=\"1524140256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSM\" target=\"_blank\">TSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346811-taiwan-semi-trims-revenue-outlook-on-softer-smartphone-demand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taiwan Semi trims revenue outlook on softer smartphone demand</a></h4><ul>     <li>Taiwan Semiconductor (NYSE:<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a>) <font color='red'>-5.3%</font> premarket after its narrow <a href=\"https://seekingalpha.com/news/3346722-taiwan-semiconductor-manufacturing-lower-4-percent-revenue-profit-miss\" target=\"_blank\">Q1 earnings</a> miss is accompanied by a <a href=\"https://www.reuters.com/article/tsmc-results/update-2-tsmc-trims-full-year-revenue-estimate-on-weaker-smartphone-demand-idUSL3N1RT1YS\" target=\"_blank\">reduction in its full-year revenue outlook</a> to the low end of its earlier guidance due to softer demand for smartphones and cryptocurrency-related chips.</li>     <li>TSM now sees FY 2018 revenue growing 10% compared with an earlier forecast of 10%-15% growth, and forecasts Q2 revenue to rise 10.5%-12% Y/Y to $7.8B-$7.9B.</li>     <li>TSM also says it expects growth this year of 5% for the global semiconductor industry, weaker than its earlier forecast of 5%-7% growth, and 8% for contract chipmakers, lower than its previous outlook for 9%-10% growth.</li>     <li>Other chipmakers also are lower, including <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-1.9%</font>, <a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='red'>-1.8%</font>, <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-0.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346811\" data-linked=\"Taiwan Semi trims revenue outlook on softer smartphone demand\" data-tweet=\"$TSM $TSM $AMD - Taiwan Semi trims revenue outlook on softer smartphone demand https://seekingalpha.com/news/3346811-taiwan-semi-trims-revenue-outlook-on-softer-smartphone-demand?source=tweet\" data-url=\"https://seekingalpha.com/news/3346811-taiwan-semi-trims-revenue-outlook-on-softer-smartphone-demand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346802\" data-ts=\"1524139408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346802-piper-jaffray-confidence-lifts-irobot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray confidence lifts iRobot</a></h4><ul> <li>Shares of iRobot (NASDAQ:<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a>) are on watch after Piper Jaffray jumps in with an upgrade to Overweight from Neutral.</li> <li>The Piper team points to strong robotic vacuum product demand in North America.</li> <li>The price target on iRobot is pushed up to $78 on the expectation for strong sales growth.</li> <li>IRBT <font color='green'>+3.56%</font> premarket to $64.00 vs. a 52-week trading range of $55.77 to $109.78.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346802\" data-linked=\"Piper Jaffray confidence lifts iRobot\" data-tweet=\"$IRBT - Piper Jaffray confidence lifts iRobot https://seekingalpha.com/news/3346802-piper-jaffray-confidence-lifts-irobot?source=tweet\" data-url=\"https://seekingalpha.com/news/3346802-piper-jaffray-confidence-lifts-irobot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346801\" data-ts=\"1524139397\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGN\" target=\"_blank\">ALGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346801-align-tech-down-3-premarket-after-ms-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Align Tech down 3% premarket after MS downgrade</a></h4><ul><li>Align Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGN' title='Align Technology, Inc.'>ALGN</a>) slips&nbsp;<font color='red'>3%</font>&nbsp;premarket, albeit on only 307 shares, on the heels of a downgrade to Equal Weight at Morgan Stanley citing growth and valuation concerns.</li><li>Evercore ISI's Ross Muken says the MS's softer view may weigh on dental peers Henry Schein (NASDAQ:<a href='https://seekingalpha.com/symbol/HSIC' title='Henry Schein, Inc.'>HSIC</a>), Patterson Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/PDCO' title='Patterson Companies Inc.'>PDCO</a>) and DENTSPLY SIRONA (NASDAQ:<a href='https://seekingalpha.com/symbol/XRAY' title='DENTSPLY SIRONA, Inc'>XRAY</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3346801\" data-linked=\"Align Tech down 3% premarket after MS downgrade\" data-tweet=\"$ALGN $ALGN $HSIC - Align Tech down 3% premarket after MS downgrade https://seekingalpha.com/news/3346801-align-tech-down-3-premarket-after-ms-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3346801-align-tech-down-3-premarket-after-ms-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346791\" data-ts=\"1524138627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHR\" target=\"_blank\">DHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346791-danaher-q1-sales-up-12-earnings-up-12-cash-flow-up-48-guidance-raised-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Danaher Q1 sales up 12%; earnings up 12%; cash flow up 48%; guidance raised; shares up 2% premarket</a></h4><ul><li>Danaher (NYSE:<a href='https://seekingalpha.com/symbol/DHR' title='Danaher Corporation'>DHR</a>) <a href=\"https://seekingalpha.com/pr/17134343-danaher-reports-first-quarter-2018-results\" target=\"_blank\">Q1 results</a> ($M): Sales: 4,695.4 (+11.6%).</li><li>Net income: 566.6 (+12.0%); EPS: 0.80 (+11.1%); non-GAAP EPS: 0.99 (+16.5%); cash flow ops: 828.9 (+48.0%).</li><li><strong>2018 Guidance</strong>: EPS: $3.62 - 3.69 from $3.50 - 3.60; non-GAAP EPS: $4.38 - 4.45 from $4.25 - 4.35.</li><li><strong>Q2 Guidance</strong>: EPS: $0.88 - 0.91; non-GAAP EPS: $1.07 - 1.10.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346720-danaher-corporation-beats-0_05-beats-revenue\" target=\"_blank\">Danaher Corporation beats by $0.05, beats on revenue</a> (April 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346791\" data-linked=\"Danaher Q1 sales up 12%; earnings up 12%; cash flow up 48%; guidance raised; shares up 2% premarket\" data-tweet=\"$DHR - Danaher Q1 sales up 12%; earnings up 12%; cash flow up 48%; guidance raised; shares up 2% premarket https://seekingalpha.com/news/3346791-danaher-q1-sales-up-12-earnings-up-12-cash-flow-up-48-guidance-raised-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3346791-danaher-q1-sales-up-12-earnings-up-12-cash-flow-up-48-guidance-raised-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346789\" data-ts=\"1524138312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346789-sleep-number-falls-after-missing-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sleep Number falls after missing its numbers</a></h4><ul> <li>Sleep Number (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>) is down sharply after falling short with its <a href=\"https://seekingalpha.com/pr/17133910-sleep-number-announces-first-quarter-2018-results\" target=\"_blank\">Q1</a> report.</li> <li>Comparable sales during the quarter fell 3% to miss the consensus estimate for a 2% decline.</li> <li>Gross profit fell 150 bps to 61.1% of sales. The retailer cites the \"inefficiencies\" of operating two supply chains as it transitions to 360 smart beds.</li> <li>Sleep Number backs its prior outlook for mid- to high-single digit sales growth in 2018 and EPS of $1.70 to $2.00.</li> <li>Shares of Sleep Number are <font color='red'>down 12.98%</font> in premarket trading to $31.77.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346619-sleep-number-misses-0_04-misses-revenue\" target=\"_blank\">Sleep Number misses by $0.04, misses on revenue</a> (April 18)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346789\" data-linked=\"Sleep Number falls after missing its numbers\" data-tweet=\"$SNBR - Sleep Number falls after missing its numbers https://seekingalpha.com/news/3346789-sleep-number-falls-after-missing-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3346789-sleep-number-falls-after-missing-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346788\" data-ts=\"1524138295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POOL\" target=\"_blank\">POOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346788-on-pool-corporations-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Pool Corporation&#39;s Q1 results</a></h4><ul><li>Pool (NASDAQ:<a href='https://seekingalpha.com/symbol/POOL' title='Pool Corporation'>POOL</a>)&nbsp;reports&nbsp;base business net sales rose 5% to $575.11M in <a href=\"https://seekingalpha.com/pr/17134438-pool-corporation-reports-record-first-quarter-results\" target=\"_blank\">Q1</a>.</li><li>Gross margin rate improved 20 bps to 28.3%.</li><li>Operating margin rate flat at 5.7%.</li><li>Adjusted EBITDA expanded 9.2% to $43.44M.</li><li>&ldquo;As a result of the additional tax benefits realized from ASU 2016-09 in the first quarter, we are updating our earnings guidance range to $5.45 to $5.70 from $5.36 to $5.61 per diluted share.&nbsp; Other than the additional $0.09 per diluted share tax benefit, our earnings expectations for 2018 remain unchanged.&nbsp; We are fortunate to participate in a great industry with strong long-term growth characteristics and our team is ready to serve our customers to help them realize success in making outdoor living come to life,&rdquo; said Perez&nbsp;de&nbsp;la&nbsp;Mesa.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346788\" data-linked=\"More on Pool Corporation&#39;s Q1 results\" data-tweet=\"$POOL - More on Pool Corporation&#39;s Q1 results https://seekingalpha.com/news/3346788-on-pool-corporations-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3346788-on-pool-corporations-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346786\" data-ts=\"1524138055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346786-novartis-q1-top-line-up-10-eps-up-23-cash-flow-up-23-shares-down-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis Q1 top line up 10%; EPS up 23%; cash flow up 23%; shares down 2% premarket</a></h4><ul><li>Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) <a href=\"https://www.novartis.com/sites/www.novartis.com/files/2018-04-interim-financial-report-en.pdf\" target=\"_blank\">Q1 results</a> ($M): Total revenues: 12,694 (+10.0%); Innovative Medicines: 8,398 (+11.7%); Sandoz: 2,517 (+3.6%); Alcon: 1,779 (+11.8%).</li><li>Net income: 2,028 (+21.8%); EPS: 0.86 (+22.9%); CF Ops: 2,514 (+22.9%).</li><li>Key product sales: Gilenya: 821 (+13.7%); Cosentyx: 580 (+41.5%); Lucentis: 520 (+16.7%); Tasigna: 466 (+13.4%); Sandostatin: 400 (+3.9%); Gleevec/Glivec: 392 (-27.9%); Jakavi: 234 (+44.4%); Kisqali: 44 (+528.6%).</li><li><strong>2018 Guidance</strong>: Total sales growth: low-to-mid-single digit; Innovative Medicines sales growth: mid-single-digit; Sandoz: flat to slight decline; Alcon: low-to-mid-single-digit.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346724-novartis-beats-0_03-beats-revenue\" target=\"_blank\">Novartis beats by $0.03, beats on revenue</a> (April 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3346786\" data-linked=\"Novartis Q1 top line up 10%; EPS up 23%; cash flow up 23%; shares down 2% premarket\" data-tweet=\"$NVS - Novartis Q1 top line up 10%; EPS up 23%; cash flow up 23%; shares down 2% premarket https://seekingalpha.com/news/3346786-novartis-q1-top-line-up-10-eps-up-23-cash-flow-up-23-shares-down-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3346786-novartis-q1-top-line-up-10-eps-up-23-cash-flow-up-23-shares-down-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346780\" data-ts=\"1524137758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BX\" target=\"_blank\">BX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346780-blackstone-beats-boosts-buyback-sets-special-payout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blackstone beats, boosts buyback, sets special payout</a></h4><ul><li>The buyback authorization is nearly tripled to $1B, though this won't be reducing the float. Repurchases will mostly be used to offset stock-based compensation.</li><li>The $0.30 per unit special distribution will be made over the next three quarters. This is thanks to $580M Blackstone (NYSE:<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a>) received after its GSO was replaced as the manager of FS Investments.</li><li>Turning to Q1 results, economic net income of $791.7M or $0.65 per share was down from $967.9M and $0.81 a year ago. Distributable earnings of $502M or $0.41 per share down from $1.2B and $1.02. Fee-related earnings were up though, to $332.9M from $290.7M.</li><li>Fee-earning AUM up 23% Y/Y to $344.7B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3346768-blackstone-beats-0_02-misses-revenue\" target=\"_blank\">Blackstone beats by $0.02, misses on revenue</a> (April 19)</li><li><a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group L.P.'>BX</a>&nbsp;<font color='green'>+1.7%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3346780\" data-linked=\"Blackstone beats, boosts buyback, sets special payout\" data-tweet=\"$BX - Blackstone beats, boosts buyback, sets special payout https://seekingalpha.com/news/3346780-blackstone-beats-boosts-buyback-sets-special-payout?source=tweet\" data-url=\"https://seekingalpha.com/news/3346780-blackstone-beats-boosts-buyback-sets-special-payout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346775\" data-ts=\"1524137406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PG\" target=\"_blank\">PG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346775-pricing-drags-on-p-and-g-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pricing drags on P&amp;G in Q1</a></h4><ul> <li>Procter &amp; Gamble (NYSE:<a href='https://seekingalpha.com/symbol/PG' title='The Procter & Gamble Company'>PG</a>) reports organic sales increased 1.0% in <a href=\"https://seekingalpha.com/pr/17134431-p-and-g-announces-third-quarter-earnings\" target=\"_blank\">Q1</a>. Product mix added to sales, while pricing was negative due largely to price cuts with U.S. shaving products.</li> <li>Organic sales increased in the beauty (+5%) and fabric &amp; home care (+3%) categories, while declining in grooming (-3%) and baby/feminine/family care (-3%).</li> <li>On a F/X-neutral basis, core gross margin fell 90 basis points as 230 basis points of productivity savings were more than offset by 100 bps of commodity cost increases. Core operating profit margin was down 70 bps.</li> <li>The company says it expects to organic sales growth to fall in the low end of the 2% to 3% guidance range. P&amp;G expects FY18 revenue of $67.0B to match the consensus estimate.</li> <li>\"We have large businesses in several difficult markets. The ecosystems in which we operate around the world are being disrupted and transformed. We will change at an even faster rate -- winning through superiority, cost and cash productivity and a strengthened organization and culture,\" says Procter &amp; Gamble CEO David Taylor in a high-level assesment.</li> <li>Shares of P&amp;G are <font color='red'>down 0.26%</font> in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3346775\" data-linked=\"Pricing drags on P&amp;G in Q1\" data-tweet=\"$PG - Pricing drags on P&amp;G in Q1 https://seekingalpha.com/news/3346775-pricing-drags-on-p-and-g-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3346775-pricing-drags-on-p-and-g-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3346773\" data-ts=\"1524137144\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3346773-appleminus-1_25-after-dour-mizuho-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple -1.25% after dour Mizuho note</a></h4><ul><li>Analyst Abhey Lamba suggests Apple could miss the midpoint of FQ3 revenue guidance, noting continued high-end inventory drain.</li><li>His team's checks show \"limited new features in upcoming product line-up, inhibiting differentiation in the high-end vs. current line-up.\" They see Q3 revenue in the $50.5B-$52.5B range vs. consensus $52B.</li><li>Lamba rates the shares at Neutral with $175 price target.</li><li>Source: Bloomberg</li><li>The stock's&nbsp;<font color='red'>lower by 1.25%</font>&nbsp;premarket to $175.60.</li></ul><div class=\"tiny-share-widget\" data-id=\"3346773\" data-linked=\"Apple -1.25% after dour Mizuho note\" data-tweet=\"Apple -1.25% after dour Mizuho note https://seekingalpha.com/news/3346773-appleminus-1_25-after-dour-mizuho-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3346773-appleminus-1_25-after-dour-mizuho-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}